UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||||||
For the quarterly period ended March 31, 2025
OR
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||||||
Commission file number 1-39361
(Exact name of registrant as specified in its charter)
| (State of incorporation) | (I.R.S. Employer Identification No.) | ||||
| (Address of principal executive offices) | (Zip Code) | ||||
(904 ) 648-8006
Registrant’s telephone number, including area code
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class | Trading Symbol | Name of Each Exchange on Which Registered | ||||||
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| ☒ | Accelerated filer | ☐ | Non-accelerated filer | ☐ | |||||||||||||
| Smaller reporting company | Emerging growth company | ||||||||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
There were 446,424,575 shares outstanding of the Registrant's common stock as of April 25, 2025.
FORM 10-Q
QUARTERLY REPORT
Quarter Ended March 31, 2025
TABLE OF CONTENTS
| Page | ||||||||
| Item 1. | ||||||||
| Item 2. | ||||||||
| Item 3. | ||||||||
| Item 4. | ||||||||
| Item 1. | ||||||||
| Item1A. | ||||||||
| Item 2. | ||||||||
| Item 3. | ||||||||
| Item 4. | ||||||||
| Item 5. | ||||||||
| Item 6. | ||||||||
2
Part I: FINANCIAL INFORMATION
Item 1. Condensed Consolidated Financial Statements (Unaudited)
Dun & Bradstreet Holdings, Inc.
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(In millions, except per share data)
(Unaudited)
| Three months ended March 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Revenue | $ | $ | |||||||||
| Cost of services (exclusive of depreciation and amortization) | |||||||||||
| Selling and administrative expenses | |||||||||||
| Depreciation and amortization | |||||||||||
| Restructuring charges | |||||||||||
| Operating costs | |||||||||||
| Operating income (loss) | |||||||||||
| Interest income | |||||||||||
| Interest expense | ( | ( | |||||||||
| Other income (expense) - net | |||||||||||
| Non-operating income (expense) - net | ( | ( | |||||||||
| Income (loss) before provision (benefit) for income taxes and equity in net income of affiliates | ( | ( | |||||||||
| Less: provision (benefit) for income taxes | ( | ||||||||||
| Equity in net income of affiliates | |||||||||||
| Net income (loss) | ( | ( | |||||||||
| Less: net (income) loss attributable to the non-controlling interest | ( | ( | |||||||||
| Net income (loss) attributable to Dun & Bradstreet Holdings, Inc. | $ | ( | $ | ( | |||||||
| Basic earnings (loss) per share of common stock attributable to Dun & Bradstreet Holdings, Inc. | $ | ( | $ | ( | |||||||
| Diluted earnings (loss) per share of common stock attributable to Dun & Bradstreet Holdings, Inc. | $ | ( | $ | ( | |||||||
| Weighted average number of shares outstanding-basic | |||||||||||
| Weighted average number of shares outstanding-diluted | |||||||||||
| Other comprehensive income (loss), net of income taxes: | |||||||||||
| Net income (loss) | $ | ( | $ | ( | |||||||
| Foreign currency adjustments: | |||||||||||
Foreign currency translation adjustments, net of tax (1) | $ | $ | ( | ||||||||
Net investment hedge derivative, net of tax (2) | ( | ||||||||||
Cash flow hedge derivative, net of tax expense (benefit) (3) | ( | ||||||||||
| Defined benefit pension plans: | |||||||||||
Prior service credit (cost), net of tax expense (benefit) (4) | ( | ( | |||||||||
Net actuarial gain (loss), net of tax expense (benefit) (5) | ( | ( | |||||||||
| Total other comprehensive income (loss), net of tax | $ | $ | ( | ||||||||
| Comprehensive income (loss), net of tax | $ | $ | ( | ||||||||
| Less: comprehensive (income) loss attributable to the non-controlling interest | ( | ( | |||||||||
| Comprehensive income (loss) attributable to Dun & Bradstreet Holdings, Inc. | $ | $ | ( | ||||||||
(1)Tax Expense (Benefit) of $(5.5 ) million and $0.6 million for the three months ended March 31, 2025 and 2024, respectively.
(2)Tax Expense (Benefit) of $(5.8 ) million and $1.7 million for the three months ended March 31, 2025 and 2024, respectively.
(3)Tax Expense (Benefit) of $(4.9 ) million and $1.6 million for the three months ended March 31, 2025 and 2024, respectively.
(4)Tax Expense (Benefit) of less than $(0.1
(5)Tax Expense (Benefit) of less than $(0.1
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
3
Dun & Bradstreet Holdings, Inc.
Condensed Consolidated Balance Sheets
(In millions, except share data and per share data)
(Unaudited)
| March 31, 2025 | December 31, 2024 | ||||||||||
| Assets | |||||||||||
| Current assets | |||||||||||
| Cash and cash equivalents | $ | $ | |||||||||
Accounts receivable, net of allowance of $ | |||||||||||
| Prepaid taxes | |||||||||||
| Other prepaids | |||||||||||
Other current assets (Note 3 and 9) | |||||||||||
| Total current assets | |||||||||||
| Non-current assets | |||||||||||
Property, plant and equipment, net of accumulated depreciation of $ | |||||||||||
Computer software, net of accumulated amortization of $ | |||||||||||
Goodwill (Notes 10 and 16) | |||||||||||
Other intangibles (Notes 10 and 16) | |||||||||||
| Deferred costs (Note 3) | |||||||||||
Other non-current assets (Note 11) | |||||||||||
| Total non-current assets | |||||||||||
| Total assets | $ | $ | |||||||||
| Liabilities | |||||||||||
| Current liabilities | |||||||||||
| Accounts payable | $ | $ | |||||||||
| Accrued payroll | |||||||||||
Short-term debt (Note 12) | |||||||||||
| Deferred revenue (Note 3) | |||||||||||
Other accrued and current liabilities (Note 11) | |||||||||||
| Total current liabilities | |||||||||||
Long-term pension and postretirement benefits (Note 6) | |||||||||||
Long-term debt (Note 12) | |||||||||||
| Deferred income tax | |||||||||||
Other non-current liabilities (Note 11) | |||||||||||
| Total liabilities | |||||||||||
Commitments and contingencies (Note 17) | |||||||||||
| Equity | |||||||||||
Common Stock, $ | |||||||||||
| Capital surplus | |||||||||||
| Accumulated deficit | ( | ( | |||||||||
Treasury Stock, | ( | ( | |||||||||
| Accumulated other comprehensive loss | ( | ( | |||||||||
| Total stockholders' equity | |||||||||||
| Non-controlling interest | |||||||||||
| Total equity | |||||||||||
Total liabilities and stockholders' equity | $ | $ | |||||||||
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
4
Dun & Bradstreet Holdings, Inc.
Condensed Consolidated Statements of Cash Flows
(In millions)
(Unaudited)
| Three months ended March 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Cash flows provided by (used in) operating activities: | |||||||||||
| Net income (loss) | $ | ( | $ | ( | |||||||
| Reconciliation of net income (loss) to net cash provided by (used in) operating activities: | |||||||||||
| Depreciation and amortization | |||||||||||
| Amortization of unrecognized pension loss (gain) | ( | ( | |||||||||
| Deferred debt issuance costs amortization and write-off | |||||||||||
| Equity-based compensation expense | |||||||||||
| Restructuring charge | |||||||||||
| Restructuring payments | ( | ( | |||||||||
| Changes in deferred income taxes | ( | ( | |||||||||
| Changes in operating assets and liabilities: | |||||||||||
| (Increase) decrease in accounts receivable | |||||||||||
| (Increase) decrease in prepaid taxes, other prepaids and other current assets | ( | ( | |||||||||
| Increase (decrease) in deferred revenue | |||||||||||
| Increase (decrease) in accounts payable | ( | ( | |||||||||
| Increase (decrease) in accrued payroll | ( | ( | |||||||||
| Increase (decrease) in other accrued and current liabilities | ( | ( | |||||||||
| (Increase) decrease in other long-term assets | ( | ||||||||||
| Increase (decrease) in long-term liabilities | ( | ( | |||||||||
| Net, other non-cash adjustments | ( | ||||||||||
| Net cash provided by (used in) operating activities | |||||||||||
| Cash flows provided by (used in) investing activities: | |||||||||||
| Cash settlements of foreign currency contracts and net investment hedges | ( | ||||||||||
| Capital expenditures | ( | ( | |||||||||
| Additions to computer software and other intangibles | ( | ( | |||||||||
Other investing activities, net | ( | ( | |||||||||
| Net cash provided by (used in) investing activities | ( | ( | |||||||||
| Cash flows provided by (used in) financing activities: | |||||||||||
Payments of dividends | ( | ( | |||||||||
| Proceeds from borrowings on Credit Facility | |||||||||||
| Proceeds from borrowings on Term Loan Facility | |||||||||||
| Payments of borrowings on Credit Facility | ( | ( | |||||||||
| Payments on Term Loan Facility | ( | ( | |||||||||
| Payment of debt issuance costs | ( | ||||||||||
Other financing activities, net (1) | ( | ( | |||||||||
| Net cash provided by (used in) financing activities | ( | ( | |||||||||
| Effect of exchange rate changes on cash and cash equivalents | ( | ( | |||||||||
| Increase (decrease) in cash and cash equivalents | |||||||||||
| Cash and Cash Equivalents, Beginning of Period | |||||||||||
| Cash and Cash Equivalents, End of Period | $ | $ | |||||||||
| Supplemental Disclosure of Cash Flow Information: | |||||||||||
| Cash Paid for: | |||||||||||
| Income taxes payments (refunds), net | $ | $ | |||||||||
| Interest | $ | $ | |||||||||
Noncash additions to computer software | $ | $ | |||||||||
(1)Higher payments in Other financing activities for the three months ended March 31, 2025 were primarily related to timing of payments for withholding tax associated with restricted stock vesting.
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
5
Dun & Bradstreet Holdings, Inc.
Condensed Consolidated Statements of Stockholders' Equity
(In millions)
(Unaudited)
| Common stock | Capital surplus | (Accumulated deficit) retained earnings | Treasury stock | Cumulative translation adjustment | Defined benefit postretirement plans | Cash flow hedging derivative | Total stockholders' equity | Non-controlling interest | Total equity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Three months ended March 31, 2024: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance, January 1, 2024 | $ | $ | $ | ( | $ | ( | $ | ( | $ | ( | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||
| Net income (loss) | — | — | ( | — | — | — | — | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity-based compensation plans | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividends declared | — | ( | — | — | — | — | — | ( | — | ( | |||||||||||||||||||||||||||||||||||||||||||||||||
Pension adjustments, net of tax benefit of less than $ | — | — | — | — | — | ( | — | ( | — | ( | |||||||||||||||||||||||||||||||||||||||||||||||||
Change in cumulative translation adjustment, net of tax expense of $ | — | — | — | — | ( | — | — | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||
Net investment hedge derivative, net of tax expense of $ | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Cash flow hedge derivative, net of tax expense of $ | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance, March 31, 2024 | $ | $ | $ | ( | $ | ( | $ | ( | $ | ( | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||
| Common stock | Capital surplus | (Accumulated deficit) retained earnings | Treasury stock | Cumulative translation adjustment | Defined benefit postretirement plans | Cash flow hedging derivative | Total stockholders' equity | Non-controlling interest | Total equity | ||||||||||||||||||||||||||||||||||||||||||||||||||
Three months ended March 31, 2025: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance, January 1, 2025 | $ | $ | $ | ( | $ | ( | $ | ( | $ | ( | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||
| Net income (loss) | — | — | ( | — | — | — | — | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity-based compensation plans | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividends declared | — | ( | — | — | — | — | — | ( | — | ( | |||||||||||||||||||||||||||||||||||||||||||||||||
Shares acquired under stock repurchase program | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pension adjustments, net of tax benefit of less than $ | — | — | — | — | — | ( | — | ( | — | ( | |||||||||||||||||||||||||||||||||||||||||||||||||
Change in cumulative translation adjustment, net of tax benefit of $ | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Net investment hedge derivative, net of tax benefit of $ | — | — | — | — | ( | — | — | ( | — | ( | |||||||||||||||||||||||||||||||||||||||||||||||||
Cash flow hedge derivative, net of tax benefit of $ | — | — | — | — | — | — | ( | ( | — | ( | |||||||||||||||||||||||||||||||||||||||||||||||||
| Balance, March 31, 2025 | $ | $ | $ | ( | $ | ( | $ | ( | $ | ( | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
6
DUN & BRADSTREET HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(Tabular dollar amounts in millions, except share data and per share data)
Note 1 --Basis of Presentation and Organization
Basis of presentation
The accompanying interim condensed consolidated financial statements of Dun & Bradstreet Holdings, Inc. and its subsidiaries ("Dun & Bradstreet," or "D&B," or "we," or "us," or "our," or the "Company") were prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP"). They should be read in conjunction with the consolidated financial statements and related notes, which appear in the consolidated financial statements for the year ended December 31, 2024, included in our Annual Report on Form 10-K and filed with the Securities and Exchange Commission ("SEC") on February 21, 2025. The condensed consolidated financial statements for interim periods do not include all disclosures required by GAAP for annual financial statements and are not necessarily indicative of results for the full year or any subsequent period. In the opinion of our management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair statement of the unaudited consolidated financial position, results of operations and cash flows at the dates and for the periods presented have been included.
All intercompany transactions and balances have been eliminated in consolidation. Where appropriate, we have reclassified certain prior year amounts to conform to the current year presentation.
Segment
We manage our business and report our financial results through the following two segments:
•North America offers Finance & Risk and Sales & Marketing data, analytics and business insights in the United States and Canada; and
•International offers Finance & Risk and Sales & Marketing data, analytics and business insights directly in the United Kingdom and Ireland ("U.K."), Northern Europe (Sweden, Norway, Denmark, Finland, Estonia and Latvia), Central Europe (Germany, Austria, Switzerland and various other central and eastern European countries) (together as "Europe"), Greater China, India and indirectly through our Worldwide Network alliances ("WWN alliances").
Clearlake transaction
On March 23, 2025, the Company entered into a definitive agreement to be acquired by Clearlake Capital Group, L.P. (“Clearlake”), subject to terms and conditions set forth in the agreement. Pursuant to the agreement, upon the consummation of the merger transaction, each share of common stock, par value $0.0001 per share, of the Company issued and outstanding immediately prior to the close will be converted into the right to receive $9.15 per share in cash. Unvested time-based or performance-based restricted stock units held by employees granted under the Company’s long-term incentive plans will be assumed by Clearlake and converted into time-based units and remain subject to terms and conditions of the Company Stock Plan. The agreement provided for a 30 -day go-shop period.
The transaction is valued at approximately $7.7 billion, including outstanding debt with an equity value of $4.1 billion. The transaction is expected to be closed in the third quarter of 2025, subject to shareholder approval and other customary closing conditions. Upon completion of the transaction, Dun & Bradstreet will become a privately held company and shares of Dun & Bradstreet common stock will no longer be listed on any public market.
Note 2 -- Recent Accounting Pronouncements
We consider the applicability and impact of all Accounting Standards Updates (“ASUs”) and applicable authoritative guidance. The ASUs not listed below were assessed and determined to be not applicable.
Recently Adopted Accounting Pronouncements
7
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) - Continued
(Tabular dollar amounts, except share data and per share data, in millions)
In November 2023, the FASB issued ASU No. 2023-07, "Segment Reporting (Topic 280)." The guidance improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. In addition, the amendments in this ASU enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss, provide new segment disclosure requirements for entities with a single reportable segment, and contain other disclosure requirements. The guidance is to be applied retrospectively to all prior periods presented in the financial statements. For public business entities, the guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years, beginning after December 15, 2024. We adopted this update during the fourth quarter of 2024. The adoption of this update did not have a material impact on our consolidated balance sheets, statements of operations and statements of cash flows.
Recently Issued Accounting Pronouncements
In November 2024, the FASB issued ASU No. 2024-03, "Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40)," which requires disaggregated disclosure of income statement expenses for public business entities. The ASU does not change the expense captions an entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. For public business entities, the guidance is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. The guidance is to be applied on a prospective basis, though retrospective application is permitted. We do not expect the adoption of this authoritative guidance to have a material impact on our consolidated balance sheets, statements of operations and statements of cash flows.
Note 3 -- Revenue
The total amount of the transaction price for our revenue contracts allocated to performance obligations that are unsatisfied (or partially unsatisfied) as of March 31, 2025 is as follows:
Remainder of 2025 | 2026 | 2027 | 2028 | 2029 | Thereafter | Total | |||||||||||||||||||||||||||||||||||
| Future revenue | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
The table of future revenue does not include any amount of variable consideration that is a sales or usage-based royalty in exchange for distinct data licenses or that is allocated to a distinct service period within a single performance obligation that is a series of distinct service periods.
Timing of Revenue Recognition
| Three months ended March 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Revenue recognized at a point in time | $ | $ | |||||||||
| Revenue recognized over time | |||||||||||
| Total revenue recognized | $ | $ | |||||||||
Contract Balances
8
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) - Continued
(Tabular dollar amounts, except share data and per share data, in millions)
At March 31, 2025 | At December 31, 2024 | ||||||||||
| Accounts receivable, net | $ | $ | |||||||||
Short-term contract assets (1) | $ | $ | |||||||||
Long-term contract assets (2) | $ | $ | |||||||||
| Short-term deferred revenue | $ | $ | |||||||||
Long-term deferred revenue (3) | $ | $ | |||||||||
(1) Included within "Other current assets" in the condensed consolidated balance sheet.
(2) Included within "Other non-current assets" in the condensed consolidated balance sheet.
(3) Included within "Other non-current liabilities" in the condensed consolidated balance sheet.
The decrease in accounts receivable of $36.0 million from December 31, 2024 to March 31, 2025 was primarily due to seasonal fluctuation.
The increase in deferred revenue of $103.3 million from December 31, 2024 to March 31, 2025 was primarily due to cash payments received or due in advance of satisfying our performance obligations, largely offset by $255.5 million of revenue recognized that was included in the deferred revenue balance at December 31, 2024.
The increase in contract assets of $3.5 million from December 31, 2024 to March 31, 2025 was primarily due to new contract assets recognized, net of new amounts reclassified to receivables during 2025, partially offset by $11.3 million of contract assets included in the balance at December 31, 2024 that were reclassified to receivable when they became unconditional.
See Note 16 for a schedule detailing the disaggregation of revenue.
Assets Recognized for the Costs to Obtain a Contract
Commission assets, net of accumulated amortization included in deferred costs, were $164.0 million and $169.3 million as of March 31, 2025 and December 31, 2024, respectively.
The amortization of commission assets was $13.0 million and $12.1 million for the three months ended March 31, 2025 and 2024, respectively.
Note 4 -- Restructuring Charges
We incurred restructuring charges (which generally consist of employee severance costs and contract terminations). These charges were incurred as a result of eliminating, consolidating, standardizing and/or automating our business functions.
Three months ended March 31, 2025 vs. Three months ended March 31, 2024
We recorded total restructuring charges of $2.9 million for the three months ended March 31, 2025, consisting of:
•Severance costs of $2.7 million under ongoing benefit arrangements. Approximately 50 employees were impacted. Most of the employees impacted exited the Company by the end of the first quarter of 2025. The cash payments for these employees will be substantially completed by the end of the third quarter of 2025; and
•Contract termination, write down of right of use assets and other exit costs, including those to consolidate or close facilities of $0.2 million.
We recorded total restructuring charges of $3.4 million for the three months ended March 31, 2024, consisting of:
•Severance costs of $2.9 million under ongoing benefit arrangements. Approximately 65 employees were impacted. Most of the employees impacted exited the Company by the end of the first quarter of 2024. The cash payments for these employees were substantially completed by the end of the third quarter of 2024; and
9
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) - Continued
(Tabular dollar amounts, except share data and per share data, in millions)
•Contract termination, write down of right of use assets and other exit costs, including those to consolidate or close facilities of $0.5 million.
The following table sets forth the restructuring reserves and utilization included within "Accrued payroll" in the condensed consolidated balance sheets for the three months ended March 31, 2025 and March 31, 2024:
| Severance | Contract termination and other exit costs | Total | |||||||||||||||
2025: | |||||||||||||||||
Balance remaining as of December 31, 2024 | $ | $ | $ | ||||||||||||||
Charge taken during first quarter 2025 (1) | |||||||||||||||||
Payments made during first quarter 2025 | ( | ( | ( | ||||||||||||||
Balance remaining as of March 31, 2025 | $ | $ | $ | ||||||||||||||
| 2024: | |||||||||||||||||
| Balance remaining as of December 31, 2023 | $ | $ | $ | ||||||||||||||
Charge taken during first quarter 2024 (1) | |||||||||||||||||
| Payments made during first quarter 2024 | ( | ( | ( | ||||||||||||||
| Balance remaining as of March 31, 2024 | $ | $ | $ | ||||||||||||||
(1)Balance excludes charges accounted for under ASU No. 2016-02, "Leases (Topic 842)."
Note 5 -- Stock Based Compensation
The following table sets forth the components of our stock-based compensation and expected tax benefit for the three months ended March 31, 2025 and 2024 related to the plans in effect during the respective period:
| Three months ended March 31, | |||||||||||
| Stock-based compensation expense: | 2025 | 2024 | |||||||||
Restricted stock and restricted stock units | $ | $ | |||||||||
Stock options (1) | |||||||||||
| Total compensation expense | $ | $ | |||||||||
| Expected tax benefit: | |||||||||||
| Restricted stock and restricted stock units | $ | $ | |||||||||
| Stock options | |||||||||||
| Total expected tax benefit | $ | $ | |||||||||
(1)Lower expense for stock options was primarily due to the impact of the accelerated attribution method used to recognize expense for the performance-based stock option grants.
Stock Options
We accounted for stock options based on grant date fair value. Service condition options were valued using the Black-Scholes valuation model. Market condition options were valued using a Monte Carlo valuation model.
The following table summarizes the stock options activity for the three months ended March 31, 2025:
10
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) - Continued
(Tabular dollar amounts, except share data and per share data, in millions)
| Stock options | |||||||||||||||||||||||
| Number of options | Weighted-average exercise price | Weighted-average remaining contractual term (in years) | Aggregate intrinsic value | ||||||||||||||||||||
Balances, January 1, 2025 | $ | $ | |||||||||||||||||||||
| Granted | $ | ||||||||||||||||||||||
| Forfeited | $ | ||||||||||||||||||||||
| Exercised | $ | ||||||||||||||||||||||
Balances, March 31, 2025 | $ | $ | |||||||||||||||||||||
Expected to vest as of March 31, 2025 | $ | $ | |||||||||||||||||||||
Exercisable as of March 31, 2025 | $ | $ | |||||||||||||||||||||
As of March 31, 2025, total unrecognized compensation cost related to stock options was $1.0 million, which was expected to be recognized over a weighted average period of 0.3 years.
Restricted Stock and Restricted Stock Units
Restricted stock and restricted stock units are valued on the award grant date at the closing market price of our stock.
The following table summarizes the restricted stock and restricted stock units activity for the three months ended March 31, 2025:
| Restricted stock and Restricted stock units | |||||||||||||||||||||||
| Number of shares | Weighted-average grant date fair value | Weighted-average remaining contractual term (in years) | Aggregate intrinsic value | ||||||||||||||||||||
Balances, January 1, 2025 | $ | $ | |||||||||||||||||||||
| Granted | $ | ||||||||||||||||||||||
| Forfeited | ( | $ | |||||||||||||||||||||
| Vested | ( | $ | |||||||||||||||||||||
Balances, March 31, 2025 | $ | $ | |||||||||||||||||||||
As of March 31, 2025, total unrecognized compensation cost related to non-vested restricted stock and restricted stock units was $84.1 million, which is expected to be recognized over a weighted average period of 2.2 years.
Employee Stock Purchase Plan ("ESPP")
Note 6 -- Pension and Postretirement Benefits
Net Periodic Pension Cost
The following table sets forth the components of the net periodic cost (income) associated with our pension plans and our postretirement benefit obligations:
11
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) - Continued
(Tabular dollar amounts, except share data and per share data, in millions)
| Pension plans | Postretirement benefit obligations | ||||||||||||||||||||||
| Three months ended March 31, | Three months ended March 31, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Components of net periodic cost (income): | |||||||||||||||||||||||
| Service cost | $ | $ | $ | $ | |||||||||||||||||||
| Interest cost | |||||||||||||||||||||||
| Expected return on plan assets | ( | ( | |||||||||||||||||||||
| Amortization of prior service cost (credit) | ( | ( | |||||||||||||||||||||
| Amortization of actuarial loss (gain) | ( | ( | |||||||||||||||||||||
| Net periodic cost (income) | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
Note 7 -- Income Taxes
The effective tax rate for the three months ended March 31, 2025 was (2.7 )%, reflecting a tax expense of $0.4 million on pre-tax loss of $14.8 million, compared to 66.0 % for the three months ended March 31, 2024, which reflected a tax benefit of $44.2 million on pre-tax loss of $67.0 million. The change in the effective tax rate for the three months ended March 31, 2025 compared to the prior year quarter was primarily the result of an uncertain tax position benefit resulting from an audit settlement in the prior year quarter.
Note 8 -- Earnings (Loss) Per Share
Basic earnings (loss) per share is computed by dividing net income (loss) for the period by the weighted-average number of common shares outstanding during the period.
In periods when we report net income, diluted earnings per share is calculated by dividing net income by the weighted average number of common shares outstanding during the period plus the dilutive effect of our outstanding stock incentive awards. For periods when we report a net loss, diluted earnings per share is equal to basic earnings per share, as the impact of our outstanding stock incentive awards is considered to be antidilutive.
The following table sets forth the computation of basic and diluted earnings (loss) per share:
| Three months ended March 31, | ||||||||||||||
| 2025 | 2024 | |||||||||||||
| Net income (loss) attributable to Dun & Bradstreet Holdings, Inc. | $ | ( | $ | ( | ||||||||||
| Weighted average number of shares outstanding-basic | ||||||||||||||
Weighted average number of shares outstanding-diluted (1) | ||||||||||||||
| Earnings (loss) per share of common stock attributable to Dun & Bradstreet Holdings, Inc.: | ||||||||||||||
| Basic | $ | ( | $ | ( | ||||||||||
| Diluted | $ | ( | $ | ( | ||||||||||
Note 9 -- Financial Instruments
The Company is exposed to global market risks, including risks from changes in foreign exchange rates and changes in interest rates. Accordingly, we use derivatives to manage the aforementioned financial exposures that occur in the normal course of business. We do not use derivatives for trading or speculative purposes. By their nature, all such instruments involve risk, including the credit risk of non-performance by counterparties. However, at March 31, 2025 and December 31, 2024, there
12
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) - Continued
(Tabular dollar amounts, except share data and per share data, in millions)
was no significant risk of loss in the event of non-performance of the counterparties to these financial instruments. We control our exposure to credit risk through monitoring procedures and by selection of reputable counterparties. Collateral is generally not required for these types of investments.
Our trade receivables do not represent a significant concentration of credit risk at March 31, 2025 and December 31, 2024, because we sell to a large number of clients in different geographical locations and industries.
Interest Rate Risk Management
Our objective in managing our exposure to interest rates is to limit the impact of interest rate changes on our earnings, cash flows and financial position, and to lower our overall borrowing costs. To achieve these objectives, we maintain a practice that floating-rate debt be managed within a minimum and maximum range of our total debt exposure. To manage our exposure and limit volatility, we may use fixed-rate debt, floating-rate debt and/or interest rate swaps. We recognize all derivative instruments as either assets or liabilities at fair value in the consolidated balance sheet.
We use interest rate swaps to manage the impact of interest rate changes on our earnings. Under the swap agreements, we make monthly payments based on the fixed interest rate and receive monthly payments based on the floating rate. The purpose of the swaps is to mitigate the variation of future cash flows from changes in the floating interest rates on our existing debt. The swaps are designated and accounted for as cash flow hedges. Changes in the fair value of the hedging instruments are recorded in other comprehensive income (loss) ("OCI"), net of tax, and reclassified to earnings in the same line item associated with the hedged item when the hedged item impacts earnings.
The following table summarizes our interest rate swaps in effect as of March 31, 2025 and December 31, 2024:
Expiration date | Fixed rate | Notional amount | ||||||||||||||||||
| March 31, 2025 | December 31, 2024 | |||||||||||||||||||
| February 27, 2025 | $ | $ | ||||||||||||||||||
| March 27, 2025 | ||||||||||||||||||||
| February 8, 2026 | ||||||||||||||||||||
| March 27, 2028 | ||||||||||||||||||||
| March 27, 2028 | ||||||||||||||||||||
| March 27, 2028 | ||||||||||||||||||||
| Total interest rate swaps | $ | $ | ||||||||||||||||||
Foreign Exchange Risk Management
Our objective in managing exposure to foreign currency fluctuations is to reduce the volatility caused by foreign exchange rate changes on the earnings, cash flows and financial position of our international operations. From time to time, we follow a practice of hedging certain balance sheet positions denominated in currencies other than the functional currency applicable to each of our various subsidiaries. In addition, we are subject to foreign exchange risk associated with our international earnings and net investments in our foreign subsidiaries. We may use short-term, foreign exchange forward and, from time to time, option contracts to execute our hedging strategies. Certain derivatives are designated as accounting hedges.
Foreign exchange forward contracts
To decrease earnings volatility, we currently hedge substantially all our intercompany balance positions denominated in a currency other than the functional currency applicable to each of our various subsidiaries with short-term, foreign exchange forward contracts. The underlying transactions and the corresponding foreign exchange forward contracts are marked to market at the end of each quarter and the fair value changes are reflected within “Non-operating income (expense) – net” in the condensed consolidated statements of operations and comprehensive income (loss).
13
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) - Continued
(Tabular dollar amounts, except share data and per share data, in millions)
These contracts are denominated primarily in the Euro, Swedish Krona, British pound sterling and Norwegian Krone. Our foreign exchange forward contracts are not designated as hedging instruments under authoritative guidance and typically have maturities of 12 months or less.
As of March 31, 2025 and December 31, 2024, the notional amounts of our foreign exchange contracts were $633.5 million and $583.5 million, respectively.
Cross-currency interest rate swaps
To protect the value of our investments in our foreign operations against adverse changes in foreign currency exchange rates, we hedge a portion of our net investment in one or more of our foreign subsidiaries by using cross-currency interest rate swaps. Cross-currency swaps are designated as net investment hedges of a portion of our foreign investments denominated in the non-U.S. dollar currency. The component of the gains and losses on our net investment in these designated foreign operations driven by changes in foreign exchange rates, are partly offset by movements in the fair value of our cross-currency swap contracts. The change in the fair value of the swaps in each period is reported in OCI, net of tax. Such amounts will remain in accumulated OCI until the liquidation or substantial liquidation of our investment in the underlying foreign operations. Through the respective maturity dates of each of the swap contracts, we receive monthly fixed-rate interest payments, which are recorded as contra expense within "Interest expense" in the condensed consolidated statements of operations and comprehensive income (loss). On the maturity date of each swap contract, we will receive the respective notional amount in USD and pay the counterparty the same in euros. The swaps are designated as net investment hedges of a portion of our foreign investments denominated in the Euro currency.
The following table summarizes our cross-currency swaps in effect as of March 31, 2025 and December 31, 2024:
| March 31, 2025 | ||||||||||||||||||||
Pay | Receive | |||||||||||||||||||
Expiration date | Notional amount | Interest rate | Notional amount | Interest rate | ||||||||||||||||
| July 19, 2026 | € | $ | ||||||||||||||||||
July 19, 2027 (1) | ||||||||||||||||||||
April 16, 2028 (1) | ||||||||||||||||||||
April 16, 2028 (1) | ||||||||||||||||||||
April 16, 2029 (1) | ||||||||||||||||||||
January 3, 2030 (1) | ||||||||||||||||||||
Total cross-currency swaps | € | $ | ||||||||||||||||||
| December 31, 2024 | ||||||||||||||||||||
Pay | Receive | |||||||||||||||||||
Expiration date | Notional amount | Interest rate | Notional amount | Interest rate | ||||||||||||||||
July 19, 2025 (2) | € | $ | ||||||||||||||||||
| July 19, 2026 | ||||||||||||||||||||
July 19, 2027 (2) | ||||||||||||||||||||
April 16, 2028 (2) | ||||||||||||||||||||
April 16, 2028 (2) | ||||||||||||||||||||
April 16, 2029 (2) | ||||||||||||||||||||
| Total cross-currency swaps | € | $ | ||||||||||||||||||
(1)These swaps were executed on January 3, 2025, replacing previously existing cross-currency swaps.
14
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) - Continued
(Tabular dollar amounts, except share data and per share data, in millions)
(2)These swaps were terminated on January 3, 2025. Upon the termination of these swaps, we paid cash of $1.1 million, which was reported in OCI at March 31, 2025, and will remain within accumulated OCI until the period in which a disposal or substantial liquidation of the entities hedged occurs.
We received aggregate interest payments of $2.3 million and $2.1 million related to cross-currency swaps for the three months ended March 31, 2025 and 2024, respectively. These payments were recorded as contra expense within "Interest expense" in the condensed consolidated statements of operations and comprehensive income (loss).
Fair Values of Derivative Instruments in the Condensed Consolidated Balance Sheets:
| Asset derivatives | Liability derivatives | ||||||||||||||||||||||||||||||||||||||||||||||
| March 31, 2025 | December 31, 2024 | March 31, 2025 | December 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||
| Balance sheet location | Fair value | Balance sheet location | Fair value | Balance sheet location | Fair value | Balance sheet location | Fair value | ||||||||||||||||||||||||||||||||||||||||
| Derivatives designated as hedging instruments: | |||||||||||||||||||||||||||||||||||||||||||||||
| Cash flow hedge derivative: | |||||||||||||||||||||||||||||||||||||||||||||||
| Interest rate swaps | Other current assets | $ | Other current assets | $ | Other accrued & current liabilities | $ | Other accrued & current liabilities | $ | |||||||||||||||||||||||||||||||||||||||
| Net investment hedge derivative: | |||||||||||||||||||||||||||||||||||||||||||||||
| Cross-currency swaps | Other current assets | Other current assets | Other accrued & current liabilities | Other accrued & current liabilities | |||||||||||||||||||||||||||||||||||||||||||
| Total derivatives designated as hedging instruments | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||
| Derivatives not designated as hedging instruments: | |||||||||||||||||||||||||||||||||||||||||||||||
| Foreign exchange forward contracts | Other current assets | $ | Other current assets | $ | Other accrued & current liabilities | $ | Other accrued & current liabilities | $ | |||||||||||||||||||||||||||||||||||||||
| Total derivatives not designated as hedging instruments | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||
| Total derivatives | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||
The Effect of Derivative Instruments on the Condensed Consolidated Statement of Operations and Comprehensive Income (Loss):
Amount of pre-tax net gain or (loss) recognized in OCI on derivative | Amount of gain or (loss) reclassified from accumulated OCI into income | Amount of gain or (loss) recognized in income on derivative | ||||||||||||||||||||||||||||||||||||||||||||||||
| Three months ended March 31, | Three months ended March 31, | Three months ended March 31, | ||||||||||||||||||||||||||||||||||||||||||||||||
| Derivatives designated as hedging instruments | 2025 | 2024 | Location of gain or (loss) reclassified from accumulated OCI into income | 2025 | 2024 | Location of gain or (loss) recognized in income on derivative | 2025 | 2024 | ||||||||||||||||||||||||||||||||||||||||||
| Cash flow hedge derivative: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest rate swaps | $ | ( | $ | Interest expense | $ | $ | Interest expense | $ | $ | |||||||||||||||||||||||||||||||||||||||||
| Net investment hedge derivative: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Cross-currency swaps | $ | ( | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||
15
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) - Continued
(Tabular dollar amounts, except share data and per share data, in millions)
| Amount of gain (loss) recognized in income on derivatives | ||||||||||||||||||||
| Three months ended March 31, | ||||||||||||||||||||
| Derivatives not designated as hedging instruments | Location of gain or (loss) recognized in income on derivatives | 2025 | 2024 | |||||||||||||||||
| Foreign exchange forward contracts | Non-operating income (expense) – net | $ | ( | $ | ||||||||||||||||
The net amount related to the interest rate swaps expected to be reclassified into earnings over the next 12 months is approximately $12 million.
Fair Value of Financial Instruments
Our financial assets and liabilities that are reflected in the condensed consolidated financial statements include derivative financial instruments, cash and cash equivalents, accounts receivable, other receivables, accounts payable, short-term borrowings and long-term borrowings.
The following table summarizes fair value measurements by level at March 31, 2025 for assets and liabilities measured at fair value on a recurring basis:
| Quoted prices in active markets for identical assets (level I) | Significant other observable inputs (level II) | Significant unobservable inputs (level III) | Balance at March 31, 2025 | ||||||||||||||||||||
| Assets: | |||||||||||||||||||||||
Cash equivalents (1) | $ | $ | $ | $ | |||||||||||||||||||
| Other current assets: | |||||||||||||||||||||||
Foreign exchange forwards (2) | $ | $ | $ | $ | |||||||||||||||||||
Interest rate swap arrangements (3) | $ | $ | $ | $ | |||||||||||||||||||
| Liabilities: | |||||||||||||||||||||||
| Other accrued and current liabilities: | |||||||||||||||||||||||
Foreign exchange forwards (2) | $ | $ | $ | $ | |||||||||||||||||||
Cross-currency swap arrangements (3) | $ | $ | $ | $ | |||||||||||||||||||
The following table summarizes fair value measurements by level at December 31, 2024 for assets and liabilities measured at fair value on a recurring basis:
16
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) - Continued
(Tabular dollar amounts, except share data and per share data, in millions)
| Quoted prices in active markets for identical assets (level I) | Significant other observable inputs (level II) | Significant unobservable inputs (level III) | Balance at December 31, 2024 | ||||||||||||||||||||
| Assets: | |||||||||||||||||||||||
Cash equivalents (1) | $ | $ | $ | $ | |||||||||||||||||||
| Other current assets: | |||||||||||||||||||||||
Foreign exchange forwards (2) | $ | $ | $ | $ | |||||||||||||||||||
Interest rate swap arrangements (3) | $ | $ | $ | $ | |||||||||||||||||||
Cross-currency swap arrangements (3) | $ | $ | $ | $ | |||||||||||||||||||
| Liabilities: | |||||||||||||||||||||||
| Other accrued and current liabilities: | |||||||||||||||||||||||
Foreign exchange forwards (2) | $ | $ | $ | $ | |||||||||||||||||||
Cross-currency swap arrangements (3) | $ | $ | $ | $ | |||||||||||||||||||
(1)The carrying value of cash equivalents represents fair value as they consist of highly liquid investments with an initial term from the date of purchase by the Company to maturity of three months or less.
(2)Fair value is determined based on observable market data and considers a factor for nonperformance in the valuation.
(3)Fair value is determined based on observable market data.
There were no transfers between Levels I and II or transfers in or transfers out of Level III in the fair value hierarchy for both the three months ended March 31, 2025 and 2024.
At March 31, 2025 and December 31, 2024, the fair value of cash and cash equivalents, accounts receivable, other receivables and accounts payable approximated carrying value due to the short-term nature of these instruments. The estimated fair values of other financial instruments subject to fair value disclosures, determined based on valuation models using discounted cash flow methodologies with market data inputs from globally recognized data providers and third-party quotes from major financial institutions (categorized as Level II in the fair value hierarchy), are as follows:
| Balance at | |||||||||||||||||||||||
| March 31, 2025 | December 31, 2024 | ||||||||||||||||||||||
| Carrying amount | Fair value | Carrying amount | Fair value | ||||||||||||||||||||
Senior Unsecured Notes | $ | $ | $ | $ | |||||||||||||||||||
| Revolving facility | $ | $ | $ | $ | |||||||||||||||||||
Term loans (1) | $ | $ | $ | $ | |||||||||||||||||||
(1)Includes short-term and long-term portions of the Term Loan Facility.
Items Measured at Fair Value on a Nonrecurring Basis
In addition to assets and liabilities that are recorded at fair value on a recurring basis, we record assets and liabilities at fair value on a nonrecurring basis as required by GAAP. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges and for acquisition accounting in accordance with the guidance in ASC 805 "Business Combinations."
Note 10 -- Goodwill and Intangible Assets
17
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) - Continued
(Tabular dollar amounts, except share data and per share data, in millions)
Computer Software and Goodwill:
| Computer software | Goodwill | |||||||||||||
| January 1, 2025 | $ | $ | ||||||||||||
Additions at cost (1) | — | |||||||||||||
| Amortization | ( | — | ||||||||||||
Other (2) | ||||||||||||||
| March 31, 2025 | $ | $ | ||||||||||||
| January 1, 2024 | $ | $ | ||||||||||||
Additions at cost (1) | — | |||||||||||||
| Amortization | ( | — | ||||||||||||
Other (2) | ( | ( | ||||||||||||
| March 31, 2024 | $ | $ | ||||||||||||
Other Intangibles:
| Customer relationships | Reacquired rights | Database | Other indefinite-lived intangibles | Other intangibles | Total | |||||||||||||||||||||||||||||||||
| January 1, 2025 | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
| Additions at cost | ||||||||||||||||||||||||||||||||||||||
| Amortization | ( | ( | ( | — | ( | ( | ||||||||||||||||||||||||||||||||
Other (2) | ||||||||||||||||||||||||||||||||||||||
| March 31, 2025 | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
| January 1, 2024 | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
| Additions at cost | ||||||||||||||||||||||||||||||||||||||
| Amortization | ( | ( | ( | — | ( | ( | ||||||||||||||||||||||||||||||||
Other (2) | ( | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||
| March 31, 2024 | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
(1)Primarily related to software-related enhancements on products and purchased software.
(2)Primarily due to the impact of foreign currency fluctuations.
Note 11 -- Other Assets and Liabilities
Other Non-Current Assets:
18
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) - Continued
(Tabular dollar amounts, except share data and per share data, in millions)
| March 31, 2025 | December 31, 2024 | ||||||||||
Right of use assets | $ | $ | |||||||||
| Prepaid pension assets | |||||||||||
| Investments | |||||||||||
| Deferred income tax | |||||||||||
| Long-term contract assets | |||||||||||
| Prepaid cloud computing fees and deferred implementation costs | |||||||||||
Long-term technology vendor contracts | |||||||||||
Other | |||||||||||
| Total | $ | $ | |||||||||
Other Accrued and Current Liabilities:
| March 31, 2025 | December 31, 2024 | ||||||||||
Accrued operating costs | $ | $ | |||||||||
| Accrued interest expense | |||||||||||
Short-term lease liability | |||||||||||
| Accrued income tax | |||||||||||
Swap liabilities (1) | |||||||||||
Other accrued liabilities | |||||||||||
| Total | $ | $ | |||||||||
(1)See Note 9 for further detail.
Other Non-Current Liabilities:
| March 31, 2025 | December 31, 2024 | ||||||||||
| Deferred revenue - long term | $ | $ | |||||||||
| U.S. tax liability associated with the 2017 Act | |||||||||||
Long-term lease liability | |||||||||||
| Liabilities for unrecognized tax benefits | |||||||||||
| Other | |||||||||||
| Total | $ | $ | |||||||||
We typically have various contractual obligations in our normal course of business, including those recorded as liabilities in our consolidated balance sheet, and certain purchase commitments that are not recognized, but are disclosed in the notes to our consolidated financial statements, such as future obligations related to our debt, operating leases, pension plans and vendor commitments. See Notes 13, 12, 7 and 20 to the consolidated financial statements for the year ended December 31, 2024 included in the 2024 Annual Report on Form 10-K for summary of our future obligations. In addition, during the first quarter of 2025, we entered into data contracts with an aggregate commitment of approximately $82 million over the next five years. Our future obligation is expected to be approximately $19 million for the remainder of 2025, $19 million, $13 million, $13 million, $14 million and $4 million in 2026, 2027, 2028, 2029 and thereafter, respectively.
Note 12 -- Notes Payable and Indebtedness
Our borrowings are summarized in the following table:
19
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) - Continued
(Tabular dollar amounts, except share data and per share data, in millions)
| March 31, 2025 | December 31, 2024 | ||||||||||||||||||||||||||||||||||||||||
| Maturity | Principal amount | Debt issuance costs and discount* | Carrying value | Principal amount | Debt issuance costs and discount* | Carrying value | |||||||||||||||||||||||||||||||||||
| Debt maturing within one year: | |||||||||||||||||||||||||||||||||||||||||
2029 Term loan B (1) | January 18, 2029 | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
| Total short-term debt | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||
| Debt maturing after one year: | |||||||||||||||||||||||||||||||||||||||||
2029 Term loan B (1) | January 18, 2029 | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
Revolving facility (1) (2) | February 15, 2029 | ||||||||||||||||||||||||||||||||||||||||
| December 15, 2029 | |||||||||||||||||||||||||||||||||||||||||
| Total long-term debt | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||
| Total debt | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||
*Initial debt issuance costs were recorded as a reduction of the carrying amount of the debt and amortized over the contractual term of the debt. Balances represent the unamortized portion of debt issuance costs and discounts.
(1) The 5.000 % Senior Unsecured Notes and the Senior Secured Credit Facilities contain certain covenants that limit our ability to incur additional indebtedness and guarantee indebtedness, create liens, engage in mergers or acquisitions, sell, transfer or otherwise dispose of assets, pay dividends and distributions or repurchase capital stock, prepay certain indebtedness and make investments, loans and advances. We were in compliance with these non-financial covenants at March 31, 2025 and December 31, 2024.
(2) The Revolving Facility contains a springing financial covenant requiring compliance with a maximum ratio of first lien net indebtedness to consolidated EBITDA of 6.75 . The financial covenant applies only if the aggregate principal amount of borrowings under the Revolving Facility and certain outstanding letters of credit exceeds 35 % of the total amount of commitments under the Revolving Facility on the last day of any fiscal quarter. The financial covenant did not apply at March 31, 2025 and December 31, 2024.
Senior Secured Credit Facilities
On February 8, 2019, the Company entered into a credit agreement governing its Senior Secured Credit Facilities (the "Senior Secured Credit Facilities"). Subsequently, the credit agreement has been amended several times. Currently, the Senior Secured Credit Facilities consist of a senior secured term loan facility and a senior secured revolving credit facility.
On January 29, 2024, we amended our credit agreement related to the then existing $451.9 million term loan with a maturity date of January 18, 2029 (the "2029 Term Loan"), to reduce its interest rate by 0.25 %, resulting in a margin spread of SOFR plus 2.75 % per annum and to increase the then existing term loan facility by $2,651.7 million to establish a new term loan with an aggregate principal amount of $3,103.6 million and a maturity date of January 18, 2029 (“2029 Term Loan B”). The proceeds from the 2029 Term Loan B were used to fully repay the previously existing term loans, including the senior secured term loan with a maturity date of February 8, 2026 (the "2026 Term Loan") and the 2029 Term Loan. As a result, we recorded a loss on debt extinguishment of $37.1 million related to the unamortized debt issuance costs associated with the then existing 2026 and 2029 Term Loan. The loss was recorded within “Non-operating income (expense)-net” for the three months ended March 31, 2024. Initial debt issuance costs of $21.6 million related to the 2029 Term Loan B were recorded as a reduction of the carrying amount of long term debt and are amortized over the contractual term of the term loan. Concurrently, we also amended our credit agreement governing the Revolving Facility to extend the maturity date to February 15, 2029, and to reduce the applicable margin by 50 basis points, resulting in a margin spread of SOFR plus 2.50 % per annum, subject to a leverage-based pricing grid. The Credit Spread Adjustment under the Revolving Facility was also removed as part of the amendment. Total fees paid associated with the amendment of the Revolving Facility were $5.0 million, which is deferred and amortized over the term of the new arrangement, together with the original unamortized deferred costs.
On November 19, 2024, we amended our credit agreement related to the 2029 Term Loan B, to reduce its interest rate by 0.50 %, resulting in a margin spread of SOFR plus 2.25 % per annum, with an additional 0.25 % step down in the applicable margin if the Company maintains a rating of at least BB- from Standard & Poor's Investors Ratings Services and at least Ba3 from Moody's Investors Service.
20
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) - Continued
(Tabular dollar amounts, except share data and per share data, in millions)
Borrowings under the Senior Secured Credit Facilities bear interest at a rate per annum equal to an applicable margin over SOFR for the interest period relevant to such borrowing, subject to interest rate floors, and secured by substantially all of the Company’s assets.
Other details of the Senior Secured Credit Facilities:
•For the 2029 Term Loan B, beginning June 30, 2024, the principal amount is required to be paid down in equal quarterly installments in an aggregate annual amount equal to 1.00 % of the original principal amount, with the balance being payable on January 18, 2029. The interest rate per annum for the 2029 Term Loan B is based on a SOFR rate plus a margin of 225 basis points subsequent to the amendment on November 19, 2024, as discussed above. The interest rate associated with the outstanding balance of the 2029 Term Loan B at March 31, 2025 and December 31, 2024 was 6.572 % and 6.588 %, respectively.
•Borrowings under the Revolving Facility bear interest at a rate per annum equal to SOFR plus 250 850 million. The available borrowings under the Revolving Facility at March 31, 2025 and December 31, 2024 were $835.0 million and $840.0 million, respectively. The interest rates associated with the outstanding balance of the Revolving Facility at March 31, 2025 and December 31, 2024 were 6.827 % and 6.870 %, respectively. Initial debt issuance costs related to the Revolving Facility were included in "Other non-current assets" on the consolidated balance sheet and are amortized over the term of the Revolving Facility.
Other
We were contingently liable under open standby letters of credit and bank guarantees issued by our banks in favor of third parties totaling $11.1 million and $9.3 million as of March 31, 2025 and December 31, 2024, respectively.
We entered into interest rate swaps and cross-currency interest rate swaps, with various maturity dates, in order to manage the impact of interest rate changes. We had interest rate swap contracts with an aggregate notional amount of $2,100 million and $2,750 million in effect as of March 31, 2025 and December 31, 2024, respectively, and cross-currency interest rate contracts with an aggregate notional amount of $625
Note 13 -- Accounts Receivable Securitization Facility
In September 2022, the Company entered into a three-year revolving securitization facility agreement to transfer customer receivables of one of our U.S. subsidiaries (“Originator”) through our bankruptcy-remote subsidiary (“SPE”) to a third-party financial institution (“Purchaser”) on a recurring basis in exchange for cash equal to the gross receivables transferred. In November 2024, the agreement was amended to extend the term date from September 9, 2025 to November 18, 2027. The facility had a monthly drawing limit of $215
The Company derecognized accounts receivable of $208.3 million and $235.8 million for the three months ended March 31, 2025 and 2024, respectively. The Company collected $208.3 million and $235.8 million of accounts receivable sold under this agreement during the three months ended March 31, 2025 and 2024, respectively. Unsold accounts receivable of $50.5 million and $95.5 million were pledged by the SPE as collateral to the Purchaser as of March 31, 2025 and December 31, 2024, respectively. As of March 31, 2025 and December 31, 2024, recourse liability related to the receivables sold that has not been collected was immaterial
Fees incurred for the facility, including fees for administrative responsibilities, during the three months ended March 31, 2025 and 2024 were $3.1 million and $3.8 million, respectively, and have been reflected within "Non-operating income (expense) – net" in the condensed consolidated statements of operations and comprehensive income (loss).
21
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) - Continued
(Tabular dollar amounts, except share data and per share data, in millions)
Cash activity related to the facility is reflected in "Net cash provided by operating activities" in the condensed consolidated statements of cash flows.
Note 14 -- Stockholders' Equity
Below is a reconciliation of our common stock issued and outstanding:
| Common Shares | Treasury Shares | Common Shares Outstanding | ||||||||||||||||||
Shares as of December 31, 2024 | ( | |||||||||||||||||||
Shares issued for the three months ended March 31, 2025 | N/A | |||||||||||||||||||
Shares forfeited for the three months ended March 31, 2025 (1) | ( | N/A | ( | |||||||||||||||||
Shares as of March 31, 2025 | ( | |||||||||||||||||||
(1)Includes shares surrendered related to payroll tax withheld for the vested restricted shares.
Stock Repurchase Program
On April 30, 2024, our Board of Directors authorized a three-year stock repurchase program, (the "2024 Stock Repurchase Program"), under which the Company may repurchase up to 10.0 million shares of its common stock. Purchases may be made from time to time in the open market at prevailing prices or in privately negotiated transactions through April 30, 2027. The repurchase program does not obligate the Company to acquire any specific number of shares and may be suspended or terminated at any time. There was no share repurchase activity during the three months ended March 31, 2025. Subsequent to entering into the definitive agreement with Clearlake on March 23, 2025, the Company will not repurchase any shares under the 2024 Stock Repurchase Program.
Stockholder Dividends
The following dividends were declared by our Board of Directors and subsequently paid during the three months ended March 31, 2025:
| Declaration Date | Record Date | Payment Date | Dividends Per Share | |||||||||||||||||
| February 6, 2025 | March 6, 2025 | March 20, 2025 | $ | |||||||||||||||||
Dividends accrued for restricted shares are contingent and payable upon vesting of the underlying restricted shares.
Pursuant to the definitive agreement entered into with Clearlake on March 23, 2025, the Company has agreed not to declare or pay any dividend in respect of any shares. See Note 1 for additional details.
Note 15 -- Accumulated Other Comprehensive Income (Loss)
22
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) - Continued
(Tabular dollar amounts, except share data and per share data, in millions)
The following table summarizes the changes in the accumulated balances for each component of accumulated other comprehensive income (loss) ("AOCI"):
| Foreign currency translation adjustments | Net investment hedge derivative | Defined benefit pension plans | Cash flow hedge derivative | Total | ||||||||||||||||||||||||||||
Balance, January 1, 2025 | $ | ( | $ | $ | ( | $ | $ | ( | ||||||||||||||||||||||||
| Other comprehensive income (loss) before reclassifications | ( | ( | ||||||||||||||||||||||||||||||
| Amounts reclassified from accumulated other comprehensive income (loss), net of tax | ( | ( | ( | |||||||||||||||||||||||||||||
Balance, March 31, 2025 | $ | ( | $ | ( | $ | ( | $ | $ | ( | |||||||||||||||||||||||
Balance, January 1, 2024 | $ | ( | $ | ( | $ | ( | $ | $ | ( | |||||||||||||||||||||||
| Other comprehensive income (loss) before reclassifications | ( | ( | ||||||||||||||||||||||||||||||
| Amounts reclassified from accumulated other comprehensive income (loss), net of tax | ( | ( | ( | |||||||||||||||||||||||||||||
Balance, March 31, 2024 | $ | ( | $ | ( | $ | ( | $ | $ | ( | |||||||||||||||||||||||
The following table summarizes the reclassifications out of AOCI:
| Amount reclassified from accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Three months ended March 31, | ||||||||||||||||||||
| Details about accumulated other comprehensive income (loss) components | Affected line item in the statement where net income (loss) is presented | 2025 | 2024 | |||||||||||||||||
| Defined benefit pension plans: | ||||||||||||||||||||
| Amortization of prior service costs | Other income (expense) - net | $ | ( | $ | ( | |||||||||||||||
| Amortization of actuarial gain/loss | Other income (expense) - net | ( | ( | |||||||||||||||||
| Cash flow hedge derivative: | ||||||||||||||||||||
| Interest rate swaps | Interest expense | ( | ( | |||||||||||||||||
| Total before tax | ( | ( | ||||||||||||||||||
| Tax benefit (expense) | ||||||||||||||||||||
| Total reclassifications for the period, net of tax | $ | ( | $ | ( | ||||||||||||||||
Note 16 -- Segment Information
Our segment disclosure is intended to provide the users of our condensed consolidated financial statements with a view of the business that is consistent with management of the Company.
We manage our business and report our financial results through the following two segments:
•North America offers Finance & Risk and Sales & Marketing data, analytics and business insights in the United States and Canada; and
•International offers Finance & Risk and Sales & Marketing data, analytics and business insights directly in the U.K., Europe, Greater China and India and indirectly through our WWN alliances.
23
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) - Continued
(Tabular dollar amounts, except share data and per share data, in millions)
Our chief operating decision maker ("CODM"), who is our Chief Executive Officer, uses adjusted EBITDA as the primary profitability measure for making decisions regarding ongoing operations. We define adjusted EBITDA as net income (loss) attributable to Dun & Bradstreet Holdings, Inc. excluding the following items: (i) depreciation and amortization; (ii) interest expense and income; (iii) income tax benefit or provision; (iv) other non-operating expenses or income; (v) equity in net income of affiliates; (vi) net income attributable to non-controlling interests; (vii) equity-based compensation; (viii) restructuring charges; (ix) merger and acquisition-related operating costs; (x) transition costs primarily consisting of non-recurring expenses associated with transformational and integration activities; and (xi) other adjustments include non-recurring charges such as legal expense associated with significant legal and regulatory matters and impairment charges.
A reconciliation of Segment Adjusted EBITDA to Net income (loss) attributable to Dun & Bradstreet Holdings, Inc. for the periods presented is as follows:
| Three months ended March 31, | |||||||||||
| 2025 | 2024 | ||||||||||
Segment Revenue: | |||||||||||
| North America | $ | $ | |||||||||
| International | |||||||||||
| Consolidated total | $ | $ | |||||||||
Segment Operating Costs:(1) | |||||||||||
| North America | $ | $ | |||||||||
| International | |||||||||||
| Consolidated total | $ | $ | |||||||||
Segment Adjusted EBITDA: | |||||||||||
| North America | $ | $ | |||||||||
| International | |||||||||||
| Consolidated total | $ | $ | |||||||||
Reconciliation of Adjusted EBITDA: | |||||||||||
Segment adjusted EBITDA | $ | $ | |||||||||
Other EBITDA - Corporate and Other | ( | ( | |||||||||
Consolidated total adjusted EBITDA | $ | $ | |||||||||
| Depreciation and amortization | ( | ( | |||||||||
| Interest expense - net | ( | ( | |||||||||
Other income (expense) - net | |||||||||||
| Equity-based compensation | ( | ( | |||||||||
| Restructuring charges | ( | ( | |||||||||
| Merger, acquisition and divestiture-related operating costs | ( | ( | |||||||||
Transition costs (2) | ( | ( | |||||||||
Other adjustments (3) | ( | ( | |||||||||
| Income (loss) before income tax provision and equity in net income of affiliates | $ | ( | $ | ( | |||||||
| Benefit (provision) for income taxes | ( | ||||||||||
| Equity in net income of affiliates | |||||||||||
| Net income (loss) attributable to non-controlling interest | ( | ( | |||||||||
| Net income (loss) attributable to Dun & Bradstreet Holdings, Inc. | $ | ( | $ | ( | |||||||
24
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) - Continued
(Tabular dollar amounts, except share data and per share data, in millions)
(1)Segment operating costs primarily include personnel costs, cloud infrastructure costs and data acquisition costs. Our CODM uses consolidated expense information to manage operations.
(2)Transition costs primarily consisting of non-recurring expenses associated with investments to transform our technology and back-office infrastructure, including investment in the architecture of our technology platforms and cloud-focused infrastructure. The transformation efforts require us to dedicate separate resources in order to develop the new cloud-based infrastructure in parallel with our current environment.
(3)Adjustments were primarily related to legal fees associated with ongoing legal matters discussed in Note 17 and impairment charges.
Other Selected Segment Financial Information:
| Three months ended March 31, | |||||||||||
| 2025 | 2024 | ||||||||||
Depreciation and amortization by segment: | |||||||||||
| North America | $ | $ | |||||||||
| International | |||||||||||
| Total segments | |||||||||||
Corporate and other (1) | |||||||||||
| Consolidated total | $ | $ | |||||||||
Cash paid for capital expenditures by segment: | |||||||||||
| Capital expenditures: | |||||||||||
| North America | $ | $ | |||||||||
| International | |||||||||||
| Total segments | |||||||||||
| Corporate and other | |||||||||||
| Consolidated total | $ | $ | |||||||||
| Additions to computer software and other intangibles: | |||||||||||
| North America | $ | $ | |||||||||
| International | |||||||||||
| Total segments | |||||||||||
| Corporate and other | |||||||||||
| Consolidated total | $ | $ | |||||||||
(1)Depreciation and amortization for Corporate and other includes incremental amortization resulting from the application of purchase accounting in connection with historical merger and acquisition transactions.
Supplemental Geographic and Disaggregated Revenue Information:
25
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) - Continued
(Tabular dollar amounts, except share data and per share data, in millions)
| March 31, 2025 | December 31, 2024 | ||||||||||
| Assets: | |||||||||||
| North America | $ | $ | |||||||||
| International | |||||||||||
| Consolidated total | $ | $ | |||||||||
| Goodwill: | |||||||||||
| North America | $ | $ | |||||||||
| International | |||||||||||
| Consolidated total | $ | $ | |||||||||
| Other intangibles: | |||||||||||
| North America | $ | $ | |||||||||
| International | |||||||||||
| Consolidated total | $ | $ | |||||||||
Other long-lived assets: (1) | |||||||||||
| North America | $ | $ | |||||||||
| International | |||||||||||
| Consolidated total | $ | $ | |||||||||
Total long-lived assets (1) | $ | $ | |||||||||
(1)Excludes deferred income tax of $4.5 million and $2.9 million as of March 31, 2025 and December 31, 2024, respectively, included within "Other non-current assets" in the condensed consolidated balance sheet. See Note 11 for additional details.
| Three months ended March 31, | |||||||||||
Disaggregated Revenue:(1) | 2025 | 2024 | |||||||||
North America:(2) | |||||||||||
| Finance & Risk | $ | $ | |||||||||
| Sales & Marketing | |||||||||||
| Total North America | $ | $ | |||||||||
| International: | |||||||||||
| Finance & Risk | $ | $ | |||||||||
| Sales & Marketing | |||||||||||
| Total International | $ | $ | |||||||||
| Total Revenue: | |||||||||||
| Finance & Risk | $ | $ | |||||||||
| Sales & Marketing | |||||||||||
| Total Revenue | $ | $ | |||||||||
(1)Our client solution sets are Finance & Risk and Sales & Marketing. Inter-segment sales are immaterial, and no single client accounted for 10% or more of our total revenue.
(2)Substantially all of the North America revenue is attributable to the United States.
Note 17 -- Contingencies
26
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) - Continued
(Tabular dollar amounts, except share data and per share data, in millions)
In the ordinary course of business, we are involved in various pending and threatened litigation and regulatory matters related to our operations, such as claims brought by our clients in connection with commercial disputes, defamation claims by subjects of our reporting, and employment claims made by our current or former employees, some of which include claims for punitive or exemplary damages. Our ordinary course litigation may also include class action lawsuits, which make allegations related to various aspects of our business. From time to time, we are also subject to regulatory investigations or other proceedings by state and federal regulatory authorities as well as authorities outside of the U.S., some of which take the form of civil investigative demands or subpoenas. Some of these regulatory inquiries may result in the assessment of fines for violations of regulations or settlements with such authorities requiring a variety of remedies. We believe that none of these actions depart from customary litigation or regulatory inquiries incidental to our business.
We review lawsuits and other legal and regulatory matters (collectively "legal proceedings") on an ongoing basis when making accrual and disclosure decisions. When assessing reasonably possible and probable outcomes, management bases its decision on its assessment of the ultimate outcome assuming all appeals have been exhausted. For legal proceedings where it has been determined that a loss is both probable and reasonably estimable, a liability based on known facts and which represents our best estimate has been recorded. Actual losses may materially differ from the amounts recorded and the ultimate outcome of our pending cases is generally not yet determinable.
While some of these matters could be material to our operating results or cash flows for any particular period if an unfavorable outcome results, at present we do not believe the ultimate resolution of currently pending legal proceedings, either individually or in the aggregate, will have a material adverse effect on our financial condition.
In addition, in the normal course of business, and including without limitation, our merger and acquisition activities, strategic relationships and financing transactions, the Company indemnifies other parties, including clients, lessors and parties to other transactions with the Company, with respect to certain matters. We have agreed to hold the other parties harmless against losses arising from a breach of representations or covenants, or arising out of other claims made against certain parties. These agreements may limit the time within which an indemnification claim can be made and the amount of the claim. The Company has also entered into indemnity obligations with its officers and directors.
Right of Publicity Class Actions
DeBose v. Dun & Bradstreet Holdings, Inc., No. 2:22-cv-00209-ES-CLW (D.N.J.)
On January 17, 2022, Plaintiff Rashad DeBose filed a Class Action Complaint against the Company, alleging that the Company used the purported class members’ names and personas to promote paid subscriptions to the Company’s Hoovers product website without consent, in violation of the Ohio right of publicity statute and Ohio common law prohibiting misappropriation of a name or likeness. On March 30, 2022, the Company filed a motion to dismiss the Complaint. The Court granted the motion and dismissed the Complaint with prejudice on March 7, 2025. The time to appeal has expired, and Plaintiff has not appealed, meaning the case has terminated. Accordingly, we will no longer report on this matter.
In accordance with ASC 450 Contingencies, the Company has no basis to determine that a loss in connection with this matter is both probable and reasonably estimable, and thus no reserve has been established.
Batis v. Dun & Bradstreet Holdings, Inc., No. 4:22-cv-01924-AGT (N.D.Cal.)
On March 25, 2022, Plaintiff Odette R. Batis filed a Class Action Complaint against the Company, alleging that the Company used the purported class members’ names and personas to promote paid subscriptions to the Company’s Hoovers product website without consent, in violation of the California right of publicity statute, California common law prohibiting misappropriation of a name or likeness and California’s Unfair Competition Law. On June 30, 2022, the Company filed a motion to dismiss the Complaint pursuant to California’s anti-SLAPP statute. On February 10, 2023, the District Court denied the motion to dismiss. The decision was subject to an automatic right of appeal, and the Company has appealed the matter to the Ninth Circuit. On January 18, 2024, the Ninth Circuit affirmed the District Court’s determination that the anti-SLAPP statute does not apply. On February 1, 2024, D&B filed a petition for rehearing or rehearing en banc seeking to vacate the Ninth Circuit ruling. Subsequently, on February 15, 2024, the Ninth Circuit issued an order stating that the petition will be held in abeyance pending the resolution of en banc rehearing of another similar case pending before the Ninth Circuit, Martinez v. ZoomInfo Technologies, Inc. (“Martinez”). On March 1, 2024, the Ninth Circuit vacated the en banc rehearing in the Martinez case and continued to hold D&B’s Petition for Rehearing in abeyance. On July 8, 2024, the Ninth Circuit granted D&B’s Petition for Rehearing, withdrew its January 18, 2024 disposition and issued a new opinion and order affirming the District Court’s determination that the anti-SLAPP statute does not apply. On July 30, 2024, a mandate was issued in the Ninth Circuit
27
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) - Continued
(Tabular dollar amounts, except share data and per share data, in millions)
and the case has returned to the District Court. On September 27, 2024, the Company filed its Answer in the District Court, denying liability and asserting affirmative defenses. Discovery has now commenced in the District Court.
In accordance with ASC 450 Contingencies, the Company is continuing to defend the claims and evaluate any potential exposure; however, at this time we have no basis to determine that a loss in connection with this matter is both probable and reasonably estimable, and thus no reserve has been established.
FTC Matter
On September 21, 2021, we agreed to enter into an Agreement Containing Consent Order (the “FTC Consent Order”) subject to acceptance by the FTC, the approval of which was finalized on April 6, 2022. The FTC Consent Order requires that we undertake specific compliance practices, recordkeeping, monitoring and reporting during its term, which ends on April 6, 2042. Our compliance with the FTC Consent Order may cause us to incur significant expenses or to reduce the availability or effectiveness of our solutions. Failure to comply with the FTC Consent Order could subject us to civil or criminal penalties or other liabilities.
As required by the Consent Order, the Company has provided regular reporting to the FTC regarding its compliance with the Consent Order and timely complied with and responded to all FTC requests for information. In November 2024, the FTC sent the Company notice regarding alleged violations of the Consent Order and a potential FTC enforcement action. The Company is discussing a potential resolution of the matter with the FTC.
In accordance with ASC 450 Contingencies, at this time, the Company has no basis to determine that a loss in connection with this matter is both probable and reasonably estimable, and thus no reserve has been established.
Note 18 -- Related Parties
The following describes certain transactions and agreements in which the Company and our affiliates, executive officers and certain directors are involved.
During the three months ended March 31, 2025 and 2024, a significant portion of D&B common stock was collectively held by entities affiliated with Bilcar, LLC ("Bilcar"), Thomas H. Lee Partners, L.P. ("THL"), and Cannae Holdings, Inc. ("Cannae Holdings").
Our Chief Executive Officer Anthony Jabbour is also a member of the board of directors of Paysafe Limited ("Paysafe"), which is an investment held by Cannae Holdings and accounted for as an equity investment. Additionally, William P. Foley, II, our Executive Chairman, also previously served as non-executive Chairman of Cannae Holdings and, since February 10, 2024, has served as Chairman, Chief Executive Officer and Chief Investment Officer of Cannae Holdings. Further, our director Richard N. Massey previously served as Chief Executive Officer and a director of Cannae Holdings until February 10, 2024, and as Vice Chairman and a director until June 19, 2024, on which date Mr. Massey ceased to serve as an executive or a director of Cannae Holdings.
In December 2022, Paysafe signed a 63-month lease agreement with D&B for the occupancy of the fourth floor of our headquarters building in Jacksonville, Florida. Total rental payments over the lease term will aggregate to $4.2 million. We recognized expense credit of $0.4 million and $0.3 million for the three months ended March 31, 2025 and 2024, respectively. We recorded $0.1 million within "Other current assets" as of March 31, 2025, and $0.1
In September 2021, we entered into a 10 -year agreement with Paysafe. Pursuant to the agreement, D&B provides data license and risk management solution services to Paysafe. The agreement is cancellable by either party without penalty at each annual anniversary of the contract effective date by providing written notice not less than 90 days prior to the anniversary date. In March 2024, we entered into an additional three-year agreement with Paysafe, pursuant to which D&B will provide Paysafe marketing solutions. Both agreements were approved by our Audit Committee. In connection with the agreements associated with Paysafe, we recognized revenue of $2.6 million and $2.1 million for the three months ended March 31, 2025 and 2024, respectively. As of March 31, 2025 and December 31, 2024, we included a receivable from Paysafe of $2.9 million and $3.5 million, respectively, within "Accounts receivable."
28
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The statements contained in this report that are not purely historical are forward-looking statements, including statements regarding expectations, hopes, intentions or strategies regarding the future. Forward-looking statements are based on Dun & Bradstreet’s management’s beliefs, as well as assumptions made by, and information currently available to, them. Forward-looking statements can be identified by words such as "anticipates," "intends," "plans," "seeks," "believes," "estimates," "expects" and similar references to future periods, or by the inclusion of forecasts or projections. Examples of forward-looking statements include, but are not limited to, statements we make regarding the outlook for our future business and financial performance, such as those contained in "Management’s Discussion and Analysis of Financial Condition and Results of Operations" ("MD&A"). Because such statements are based on expectations as to future financial and operating results and are not statements of fact, actual results may differ materially from those projected. It is not possible to predict or identify all risk factors. Consequently, the risks and uncertainties listed below should not be considered a complete discussion of all of our potential trends, risks and uncertainties. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
The risks and uncertainties that forward-looking statements are subject to include, but are not limited to: (i) the possibility that the proposed acquisition of the Company by Clearlake Capital Group L.P., which is subject to the satisfaction of the customary closing conditions, does not close in the expected timeframe or at all; (ii) our ability to implement and execute our strategic plans to transform the business; (iii) our ability to develop or sell solutions in a timely manner or maintain client relationships; (iv) competition for our solutions; (v) harm to our brand and reputation; (vi) unfavorable global economic conditions including, but not limited to, volatility in interest rates, foreign currency markets, trade restrictions and tariffs, inflation, and supply chain disruptions; (vii) risks associated with operating and expanding internationally; (viii) failure to prevent cybersecurity incidents or the perception that confidential information is not secure; (ix) failure in the integrity of our data or systems; (x) system failures and personnel disruptions, which could delay the delivery of our solutions to our clients; (xi) loss of access to data sources or ability to transfer data across the data sources in markets where we operate; (xii) failure of our software vendors and network and cloud providers to perform as expected or if our relationship is terminated; (xiii) loss or diminution of one or more of our key clients, business partners or government contracts; (xiv) dependence on strategic alliances, joint ventures and acquisitions to grow our business; (xv) our ability to protect our intellectual property adequately or cost-effectively; (xvi) claims for intellectual property infringement; (xvii) interruptions, delays or outages to subscription or payment processing platforms; (xviii) risks related to artificial intelligence systems and machine learning (xix) risks related to acquiring and integrating businesses and divestitures of existing businesses; (xx) our ability to retain members of the senior leadership team and attract and retain skilled employees; (xxi) compliance with governmental laws and regulations; (xxii) risks related to registration and other rights held by certain of our largest shareholders; (xxiii) an outbreak of disease, global or localized health pandemic or epidemic, or the fear of such an event, including the global economic uncertainty and measures taken in response; (xxiv) increased economic uncertainty related to the ongoing conflict between Russia and Ukraine, the conflict in the Middle East, and associated trends in macroeconomic conditions, and (xxv) the other factors described under the headings “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and elsewhere in our consolidated financial statements for the year ended December 31, 2024, included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on February 21, 2025, as well as the unaudited consolidated financial statements and the related notes presented in Part I, Item 1, of this Quarterly Report on Form 10-Q and the Company’s other reports or documents filed with the SEC.
The following discussion and analysis of Dun & Bradstreet Holdings, Inc.’s financial condition and results of operations is provided as a supplement to the unaudited condensed consolidated financial statements for the three months ended March 31, 2025, and should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2024, our “Risk Factors,” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 21, 2025. References in this discussion and analysis to “the Company,” “Dun & Bradstreet,” “D&B,” “we,” “us” and “our” refer to Dun & Bradstreet Holdings, Inc. and its subsidiaries.
Business Overview
Dun & Bradstreet is a leading global provider of business decisioning data and analytics. Our mission is to deliver a global network of trust, enabling clients to transform uncertainty into confidence, risk into opportunity and potential into prosperity. Clients embed our trusted, end-to-end solutions into their daily workflows to inform commercial credit decisions, evaluate whether suppliers and other third parties are financially viable, reputable, compliant and resilient, enhance salesforce productivity and gain visibility into key markets. Our solutions support our clients’ mission critical business operations by providing proprietary and curated data and analytics to help drive informed decisions and improved outcomes.
Leveraging our category-defining commercial credit data and analytics, our Finance & Risk solutions are used in the critical decisioning processes of finance, risk, compliance and procurement departments worldwide. We are a market leader in
29
commercial credit decisioning, with many of the top businesses in the world utilizing our solutions to make informed decisions when considering extending business loans and trade credit. We are also a leading provider of data and analytics to businesses looking to analyze supplier relationships and more effectively collect outstanding receivables. We believe our proprietary Paydex score, a numerical indicator based on promptness of a business's payments to its suppliers and vendors, is widely relied upon as an important measure of credit health for businesses. We are well positioned to provide accessible and actionable insights and analytics that mitigate risk and uncertainty, and ultimately protect and drive increased profitability for our clients.
Our Sales & Marketing solutions combine firmographic, personal contact, intent and non-traditional, or alternative data to assist clients in optimizing their sales and marketing strategy by cleansing customer relationship management ("CRM") data and narrowing their focus and efforts on the highest probability prospects. As global competition continues to intensify, businesses need assistance with focusing their sales pipelines into a condensed list so that they can have their best sellers target the highest probability return accounts. We provide invaluable insights into businesses that can help our clients grow their businesses in a more efficient and effective manner.
We leverage these differentiated capabilities to serve a broad set of clients across multiple industries and geographies. As of December 31, 2024, we had a global client base of approximately 215,000, including some of the largest companies in the world. Our data and analytics support a wide range of use cases covering nearly all industry verticals, including financial services, technology, communications, government, retail, transportation and manufacturing. In terms of our geographic footprint, we have an industry-leading presence in North America, an established presence in the United Kingdom and Ireland ("U.K."), Northern Europe (Sweden, Norway, Denmark, Finland, Estonia and Latvia), Central Europe (Germany, Austria, Switzerland and various other central and eastern European countries) (together as "Europe"), Greater China and India through our majority or wholly-owned subsidiaries and a broader global presence through our Worldwide Network alliances ("WWN alliances").
We believe that we have an attractive business model that is underpinned by highly recurring, diversified revenue, significant operating leverage, low capital requirements and strong free cash flow. The proprietary and embedded nature of our data and analytics solutions and the integral role that we play in our clients’ decision-making processes have historically translated into high client retention and revenue visibility. We also benefit from strong operating leverage given our centralized database and solutions, which allow us to generate strong contribution margins and free cash flow.
Segments
Our segment disclosure is intended to provide the users of our unaudited condensed consolidated financial statements with a view of the business that is consistent with management of the Company.
We manage our business and report our financial results through the following two segments:
•North America offers Finance & Risk and Sales & Marketing data, analytics and business insights in the United States and Canada; and
•International offers Finance & Risk and Sales & Marketing data, analytics and business insights directly in the U.K., Europe, Greater China, India and indirectly through our WWN alliances.
Recent Developments
Clearlake transaction
On March 23, 2025, the Company entered into a definitive agreement to be acquired by Clearlake Capital Group, L.P. (“Clearlake”), subject to terms and conditions set forth in the agreement. Pursuant to the agreement, upon the consummation of the merger transaction, each share of common stock, par value $0.0001 per share, of the Company issued and outstanding immediately prior to the close will be converted into the right to receive $9.15 per share in cash. Unvested time-based or performance-based restricted stock units held by employees granted under the Company’s long-term incentive plans will be assumed by Clearlake and converted into time-based units and remain subject to terms and conditions of the Company Stock Plan. The agreement provided for a 30-day go-shop period.
The transaction is valued at approximately $7.7 billion, including outstanding debt with an equity value of $4.1 billion. The transaction is expected to be closed in the third quarter of 2025, subject to shareholder approval and other customary closing conditions. Upon completion of the transaction, Dun & Bradstreet will become a privately held company and shares of Dun & Bradstreet common stock will no longer be listed on any public market.
The following developments impact the year-over-year comparability of our results of operations, balance sheet and cash flows:
30
Debt Refinancing
On January 29, 2024, we amended our credit agreement related to the existing $451.9 million 2029 Term Loan, to reduce its interest rate by 0.25% resulting in a margin spread of SOFR plus 2.75% per annum and to increase the term loan facility by $2,651.7 million to establish a new term loan with an aggregate principal amount of $3,103.6 million (“2029 Term Loan B”) and a maturity date of January 18, 2029. The proceeds from the 2029 Term Loan B were used to fully repay the existing term loans, including the 2026 Term Loan and the 2029 Term Loan. Concurrently, we also amended our credit agreement governing the Revolving Facility to extend the maturity date to February 15, 2029, and to reduce the applicable margin by 50 basis points, resulting in a margin spread of SOFR plus 2.50% per annum, subject to a leverage-based pricing grid. The Credit Spread Adjustment under the Revolving Facility was also removed as part of the amendment.
On November 19, 2024, we amended our credit agreement related to the then existing 2029 Term Loan B, to reduce its interest rate by 0.50%, resulting in a margin spread of SOFR plus 2.25% per annum, with an additional 0.25% step down in the applicable margin if the Company maintains a rating of at least BB- from Standard & Poor's Investors Ratings Services and at least Ba3 from Moody's Investors Service.
See Note 12 to the unaudited condensed consolidated financial statements for further discussion.
Stock Repurchase Program
On April 30, 2024, our Board of Directors authorized a three-year stock repurchase program, (the "2024 Stock Repurchase Program"), under which the Company may repurchase up to 10.0 million shares of its common stock. Purchases may be made from time to time in the open market at prevailing prices or in privately negotiated transactions through April 30, 2027. The repurchase program does not obligate the Company to acquire any specific number of shares and may be suspended or terminated at any time. Since the inception of the 2024 Stock Repurchase Program, we have repurchased 961,360 shares of common stock for $9.3 million, net of accrued excise tax, at an average price of $9.71 per share. There was no share repurchase activity during the three months ended March 31, 2025.
Impacts from Macroeconomic Conditions
Our business is impacted by general economic conditions and exposed to global market volatility and uncertainties from the evolving macroeconomic environment and ongoing effects of geopolitical conflicts, such as fluctuations in foreign currency exchange rates, changes in interest rates and inflation trends, and potential economic slowdowns. Approximately 30% of our revenues are generated from non-U.S. markets. Fluctuation of U.S. dollar exchange rates against currencies of markets where we operate, in particular the Euro, British Pound and Swedish Krona, may adversely impact our revenue and profits. See further discussion within the revenue section of the MD&A.
Uncertainty remains in the outlook for U.S. economic growth and economic exposure related to global trade tensions. The adoption and expansion of trade restrictions and other governmental action related to tariffs has the potential to increase inflation and adversely impact global economic growth. In addition, the global economy continues to be impacted by geopolitical conflicts, including the Russian-Ukraine war and the conflicts in the Middle East. Uncertain economic conditions or an economic downturn could result in cautious commercial spending and lower discretionary spending, and consequently lower demand for our solutions. Disruptions in the financial markets could limit the ability or willingness of our clients to extend credit to their customers or cause our clients to constrain budgets, which could adversely impact demand for our data and analytics solutions.
While our financial performance has not been impacted materially by these events, the broader implications of these macro events on our business are difficult to predict and depend on, among many factors, their ultimate impact to our customers, vendors, and the financial markets. We will remain flexible so that we can adjust to events and uncertainties while we continue to move forward.
Recent Accounting Pronouncements
See Note 2 to the unaudited condensed consolidated financial statements for disclosure of the impact that recent accounting pronouncements may have on the unaudited condensed consolidated financial statements.
Key Components of Results of Operations
Revenue
We generate our North America and International segment revenue primarily through subscription-based contractual arrangements that we enter into with clients to provide data, analytics and analytics-related services either individually, or as
31
part of an integrated offering of multiple services. These arrangements occasionally include offerings from more than one business unit to the same client.
• We provide Finance & Risk solutions that offer clients access to our most complete and up-to-date global information, comprehensive monitoring and portfolio analysis. We also provide various business information reports that are consumed in a transactional manner across multiple platforms. Clients also use our services to manage supply chain risks and comply with anti-money laundering and global anti-bribery and corruption regulations.
• We generate our Sales & Marketing solutions revenue by providing sophisticated analytics and solutions to help our clients increase revenue from new and existing businesses, enabling B2B sales and marketing professionals to accelerate sales, enhance go-to-market activity, engage clients in a meaningful way, close business faster and improve efficiency in advertising campaigns.
Expenses
Cost of Services (exclusive of depreciation and amortization)
We define cost of services as those expenses that are directly related to producing our products, services and solutions. These expenses primarily include data fees, costs related to our databases, service fulfillment costs, call center and technology support costs, hardware and software maintenance costs, telecommunication expenses, personnel-related costs associated with these functions and occupancy costs associated with the facilities where these functions are performed.
Selling and Administrative Expenses
Selling and administrative expenses primarily include personnel-related costs for sales, administrative and corporate management employees, costs for professional and consulting services, advertising and occupancy and facilities expense of these functions.
Depreciation and Amortization
Depreciation and amortization expenses consist of depreciation related to investments in property, plant and equipment, as well as amortization of purchased and developed software and other intangible assets, principally database and client relationships recognized in connection with historical merger and acquisition transactions.
Non-Operating Income and (Expense) - Net
Non-operating income and (expense) - net includes interest expense, interest income, non-service pension income and cost components, costs associated with early debt repayments, fees associated with our accounts receivable securitization facility and our credit facility, mark-to-market expense related to certain derivatives, and other non-operating income and expenses.
Provision for Income Tax Expense (Benefit)
Provision for income tax expense (benefit) represents international, U.S. federal, state and local income taxes based on income in multiple jurisdictions for our corporate subsidiaries. Additionally, we recognize interest and penalties related to unrecognized tax benefits in provision (benefit) for income taxes.
Key Metrics
In addition to reporting GAAP results, we evaluate performance and report our results on the non-GAAP financial measures discussed below. We believe that the presentation of these non-GAAP measures provides useful information to investors and rating agencies regarding our results, operating trends and performance between periods. These non-GAAP financial measures include organic revenue, adjusted earnings before interest, taxes, depreciation and amortization ("adjusted EBITDA"), adjusted EBITDA margin, adjusted net income and adjusted net earnings per diluted share. Adjusted results are non-GAAP measures that adjust for the impact due to certain acquisition and divestiture related revenue and expenses, such as costs for banker fees, legal fees, due diligence, retention payments and contingent consideration adjustments, restructuring charges, equity-based compensation, transition costs and other non-core gains and charges that are not in the normal course of our business, such as costs associated with early debt redemptions, gains and losses on sales of businesses, impairment charges, the effect of significant changes in tax laws and material tax and legal settlements. We exclude amortization of recognized intangible assets resulting from the application of purchase accounting because it is non-cash and not indicative of our ongoing and underlying operating performance. Intangible assets are recognized as a result of historical merger and acquisition
32
transactions. We believe that recognized intangible assets by their nature are fundamentally different from other depreciating assets that are replaced on a predictable operating cycle. Unlike other depreciating assets, such as developed and purchased software licenses or property and equipment, there is no replacement cost once these recognized intangible assets expire and the assets are not replaced. Additionally, our costs to operate, maintain and extend the life of acquired intangible assets and purchased intellectual property are reflected in our operating costs as personnel, data fees, facilities, overhead and similar items. Management believes it is important for investors to understand that such intangible assets were recorded as part of purchase accounting and contribute to revenue generation. Amortization of recognized intangible assets will recur in future periods until such assets have been fully amortized. In addition, we isolate the effects of changes in foreign exchange rates on our revenue growth because we believe it is useful for investors to be able to compare revenue from one period to another, both after and before the effects of foreign exchange rate changes. The change in revenue performance attributable to foreign currency rates is determined by converting both our prior and current periods’ foreign currency revenue by a constant rate. As a result, we monitor our revenue growth both after and before the effects of foreign exchange rate changes. We believe that these supplemental non-GAAP financial measures provide management and other users with additional meaningful financial information that should be considered when assessing our ongoing performance and comparability of our operating results from period to period. Our management regularly uses our supplemental non-GAAP financial measures internally to understand, manage and evaluate our business and make operating decisions. These non-GAAP measures are among the factors management uses in planning for and forecasting future periods. Non-GAAP financial measures should be viewed in addition to, and not as an alternative to our reported results prepared in accordance with GAAP.
Our non-GAAP or adjusted financial measures reflect adjustments based on the following items, as well as the related income tax.
Organic Revenue
We define organic revenue as reported revenue before the effect of foreign exchange excluding revenue from acquired businesses, if applicable, for the first twelve months. In addition, organic revenue excludes current and prior year revenue associated with divested businesses, if applicable. We believe the organic measure provides investors and analysts with useful supplemental information regarding the Company’s underlying revenue trends by excluding the impact of acquisitions and divestitures.
Adjusted EBITDA and Adjusted EBITDA Margin
We define adjusted EBITDA as net income (loss) attributable to Dun & Bradstreet Holdings, Inc. excluding the following items:
•depreciation and amortization;
•interest expense and income;
•income tax benefit or provision;
•other non-operating expenses or income;
•equity in net income of affiliates;
•net income attributable to non-controlling interests;
•equity-based compensation;
•restructuring charges;
•merger, acquisition and divestiture-related operating costs;
•transition costs primarily consisting of non-recurring expenses associated with investments to transform our technology and back-office infrastructure, including investment in the architecture of our technology platforms and cloud-focused infrastructure. The transformation efforts require us to dedicate separate resources in order to develop the new cloud-based infrastructure in parallel with our current environment. These costs, as well as other expenses associated with transformational activities, are incremental and redundant costs that will not recur after we achieve our objectives and are not representative of our underlying operating performance. We believe that excluding these costs from our non-GAAP measures provides a better reflection of our ongoing cost structure; and
•other adjustments include non-recurring charges such as legal expense associated with significant legal and regulatory matters and impairment charges.
33
We calculate adjusted EBITDA margin by dividing adjusted EBITDA by revenue.
Adjusted Net Income
We define adjusted net income as net income (loss) attributable to Dun & Bradstreet Holdings, Inc. adjusted for the following items:
•incremental amortization resulting from the application of purchase accounting. We exclude amortization of recognized intangible assets resulting from the application of purchase accounting because it is non-cash and is not indicative of our ongoing and underlying operating performance. The Company believes that recognized intangible assets by their nature are fundamentally different from other depreciating assets that are replaced on a predictable operating cycle. Unlike other depreciating assets, such as developed and purchased software licenses or property and equipment, there is no replacement cost once these recognized intangible assets expire and the assets are not replaced. Additionally, the Company’s costs to operate, maintain and extend the life of acquired intangible assets and purchased intellectual property are reflected in the Company’s operating costs as personnel, data fees, facilities, overhead and similar items;
•equity-based compensation;
•restructuring charges;
•merger, acquisition and divestiture-related operating costs;
•transition costs primarily consisting of non-recurring expenses associated with investments to transform our technology and back-office infrastructure, including investment in the architecture of our technology platforms and cloud-focused infrastructure. The transformation efforts require us to dedicate separate resources in order to develop the new cloud-based infrastructure in parallel with our current environment. These costs, as well as other expenses associated with transformational activities, are incremental and redundant costs that will not recur after we achieve our objectives and are not representative of our underlying operating performance. We believe that excluding these costs from our non-GAAP measures provides a better reflection of our ongoing cost structure;
•merger, acquisition and divestiture-related non-operating costs;
•debt refinancing and extinguishment costs;
•non-operating pension-related income (expenses) includes certain costs and income associated with our pension and postretirement plans, consisting of interest cost, expected return on plan assets and amortized actuarial gains or losses, prior service credits and if applicable, plan settlement charges. These adjustments are non-cash and market-driven, primarily due to the changes in the value of pension plan assets and liabilities which are tied to financial market performance and conditions;
•non-cash gain and loss resulting from the modification of our interest rate swaps;
•other adjustments include non-recurring charges such as legal expense associated with significant legal and regulatory matters and impairment charges;
•tax effect of the non-GAAP adjustments; and
•other tax effect adjustments related to the tax impact of statutory tax rate changes on deferred taxes and other discrete items.
Adjusted Net Earnings Per Diluted Share
We calculate adjusted net earnings per diluted share by dividing adjusted net income (loss) by the weighted average number of common shares outstanding for the period plus the dilutive effect of common shares potentially issuable in connection with awards outstanding under our stock incentive plan.
Results of Operations
GAAP Results (In millions except per share data):
34
| Three months ended March 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Revenue | $ | 579.8 | $ | 564.5 | |||||||
Cost of services (exclusive of depreciation and amortization) | 227.8 | 224.1 | |||||||||
Selling and administrative expenses | 169.1 | 176.4 | |||||||||
| Depreciation and amortization | 144.7 | 144.0 | |||||||||
| Restructuring charges | 2.9 | 3.4 | |||||||||
| Operating costs | 544.5 | 547.9 | |||||||||
| Operating income (loss) | 35.3 | 16.6 | |||||||||
| Interest income | 1.5 | 1.6 | |||||||||
| Interest expense | (52.9) | (85.3) | |||||||||
| Other income (expense) - net | 1.3 | 0.1 | |||||||||
| Non-operating income (expense) - net | (50.1) | (83.6) | |||||||||
| Income (loss) before provision (benefit) for income taxes and equity in net income of affiliates | (14.8) | (67.0) | |||||||||
| Less: provision (benefit) for income taxes | 0.4 | (44.2) | |||||||||
| Equity in net income of affiliates | 0.4 | 0.9 | |||||||||
| Net income (loss) | (14.8) | (21.9) | |||||||||
| Less: net (income) loss attributable to the non-controlling interest | (1.0) | (1.3) | |||||||||
| Net income (loss) attributable to Dun & Bradstreet Holdings, Inc. | $ | (15.8) | $ | (23.2) | |||||||
| Basic earnings (loss) per share of common stock attributable to Dun & Bradstreet Holdings, Inc. | $ | (0.04) | $ | (0.05) | |||||||
| Diluted earnings (loss) per share of common stock attributable to Dun & Bradstreet Holdings, Inc. | $ | (0.04) | $ | (0.05) | |||||||
| Weighted average number of shares outstanding-basic | 433.3 | 431.6 | |||||||||
| Weighted average number of shares outstanding-diluted | 433.3 | 431.6 | |||||||||
Net income (loss) margin (1) | (2.7) | % | (4.1) | % | |||||||
(1)Net income (loss) margin is defined as Net income (loss) attributable to Dun & Bradstreet Holdings, Inc. divided by Revenue.
The table below sets forth our key performance measures including non-GAAP measures for the periods indicated (In millions, except per share data):
| Three months ended March 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Total revenue | $ | 579.8 | $ | 564.5 | |||||||
| Adjusted EBITDA | $ | 210.9 | $ | 201.3 | |||||||
| Adjusted EBITDA margin | 36.4 | % | 35.7 | % | |||||||
| Adjusted net income | $ | 90.9 | $ | 85.0 | |||||||
Adjusted net earnings per diluted share | $ | 0.21 | $ | 0.20 | |||||||
Reconciliations of non-GAAP financial measures to the most directly comparable GAAP financial measures are presented in the tables below (In millions, except per share amounts):
35
| Three months ended March 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Net income (loss) attributable to Dun & Bradstreet Holdings, Inc. | $ | (15.8) | $ | (23.2) | |||||||
| Depreciation and amortization | 144.7 | 144.0 | |||||||||
| Interest expense - net | 51.4 | 83.7 | |||||||||
| (Benefit) provision for income tax - net | 0.4 | (44.2) | |||||||||
| EBITDA | $ | 180.7 | $ | 160.3 | |||||||
| Other income (expense) - net | (1.3) | (0.1) | |||||||||
| Equity in net income of affiliates | (0.4) | (0.9) | |||||||||
| Net income (loss) attributable to non-controlling interest | 1.0 | 1.3 | |||||||||
| Equity-based compensation | 14.7 | 17.9 | |||||||||
| Restructuring charges | 2.9 | 3.4 | |||||||||
| Merger, acquisition and divestiture-related operating costs | 2.5 | 0.2 | |||||||||
| Transition costs | 9.6 | 17.4 | |||||||||
Other adjustments | 1.2 | 1.8 | |||||||||
| Adjusted EBITDA | $ | 210.9 | $ | 201.3 | |||||||
| North America | $ | 166.2 | $ | 152.1 | |||||||
| International | 60.5 | 64.3 | |||||||||
| Corporate and other | (15.8) | (15.1) | |||||||||
| Adjusted EBITDA | $ | 210.9 | $ | 201.3 | |||||||
| Three months ended March 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Net income (loss) attributable to Dun & Bradstreet Holdings, Inc. | $ | (15.8) | $ | (23.2) | |||||||
| Incremental amortization of intangible assets resulting from the application of purchase accounting | 102.5 | 110.8 | |||||||||
| Equity-based compensation | 14.7 | 17.9 | |||||||||
| Restructuring charges | 2.9 | 3.4 | |||||||||
| Merger, acquisition and divestiture-related operating costs | 2.5 | 0.2 | |||||||||
| Transition costs | 9.6 | 17.4 | |||||||||
Merger, acquisition and divestiture-related non-operating costs | — | 0.1 | |||||||||
| Debt refinancing and extinguishment costs | 0.2 | 37.1 | |||||||||
| Non-operating pension-related income | (5.7) | (5.0) | |||||||||
Non-cash gain (loss) from interest rate swap amendment (1) | 4.6 | (7.8) | |||||||||
Other adjustments | 1.2 | 1.8 | |||||||||
| Tax impact of non-GAAP adjustments | (26.5) | (63.6) | |||||||||
| Other tax effect adjustments | 0.7 | (4.1) | |||||||||
Adjusted net income (loss) attributable to Dun & Bradstreet Holdings, Inc. | $ | 90.9 | $ | 85.0 | |||||||
Adjusted net earnings per diluted share | $ | 0.21 | $ | 0.20 | |||||||
| Weighted average number of shares outstanding - diluted | 438.0 | 435.7 | |||||||||
(1)Amount represents non-cash amortization gain and loss resulted from the amendment of our interest rate swap derivatives. The amount is reported within "Interest expense-net" for the three months ended March 31, 2025 and 2024. See Note 9 to the unaudited condensed consolidated financial statements for a more detailed discussion.
36
Revenue
Three months ended March 31, 2025 versus Three months ended March 31, 2024
Total revenue was $579.8 million for the three months ended March 31, 2025, compared to $564.5 million for the three months ended March 31, 2024, an increase of $15.3 million, or 2.7% (3.6% before the effect of foreign exchange). The increase was attributable to growth in the underlying business and the positive impact of foreign exchange.
Excluding the negative impact of foreign exchange of $4.9 million, total organic revenue increased $20.2 million, or 3.6%, reflecting growth across both of our segments. The changes in revenue are discussed further in the segment level discussion below.
Revenue by segment was as follows (In millions):
| Three months ended March 31, | |||||||||||||||||||||||
| 2025 | 2024 | $ Increase (decrease) | % Increase (decrease) | ||||||||||||||||||||
| North America: | |||||||||||||||||||||||
| Finance & Risk | $ | 216.6 | $ | 208.1 | $ | 8.5 | 4.1 | % | |||||||||||||||
| Sales & Marketing | 181.4 | 178.5 | 2.9 | 1.6 | % | ||||||||||||||||||
| Total North America | $ | 398.0 | $ | 386.6 | $ | 11.4 | 2.9 | % | |||||||||||||||
| International: | |||||||||||||||||||||||
| Finance & Risk | $ | 122.8 | $ | 120.0 | $ | 2.8 | 2.3 | % | |||||||||||||||
| Sales & Marketing | 59.0 | 57.9 | 1.1 | 1.9 | % | ||||||||||||||||||
| Total International | $ | 181.8 | $ | 177.9 | $ | 3.9 | 2.2 | % | |||||||||||||||
| Total Revenue: | |||||||||||||||||||||||
| Finance & Risk | $ | 339.4 | $ | 328.1 | $ | 11.3 | 3.4 | % | |||||||||||||||
| Sales & Marketing | 240.4 | 236.4 | 4.0 | 1.7 | % | ||||||||||||||||||
| Total Revenue | $ | 579.8 | $ | 564.5 | $ | 15.3 | 2.7 | % | |||||||||||||||
North America Segment
For the three months ended March 31, 2025, North America revenue increased $11.4 million, or 2.9% ( 3.1% before the effect of foreign exchange) compared to the three months ended March 31, 2024. See further discussion below on revenue by solutions.
Finance & Risk
For the three months ended March 31, 2025, North America Finance & Risk revenue increased $8.5 million, or 4.1% (4.3% before the effect of foreign exchange) compared to the three months ended March 31, 2024, primarily due to increased revenue of approximately $7 million from our Finance solutions and approximately $2 million across our Third Party Risk and Supply Chain Management solutions.
Sales & Marketing
For the three months ended March 31, 2025, North America Sales & Marketing revenue increased $2.9 million, or 1.6% (1.7% before the effect of foreign exchange) compared to the three months ended March 31, 2024, primarily driven by higher revenue from our Master Data Management solutions.
International Segment
For the three months ended March 31, 2025, International revenue increased $3.9 million, or 2.2% (4.7% before the effect of foreign exchange) compared to the three months ended March 31, 2024. Excluding the negative impact of foreign exchange of $4.4 million, International organic revenue increased $8.3 million, or 4.7%. See further discussion below on revenue by solutions.
37
Finance & Risk
For the three months ended March 31, 2025, International Finance & Risk revenue increased $2.8 million, or 2.3% (4.9% before the effect of foreign exchange) compared to the three months ended March 31, 2024. Excluding the negative impact of foreign exchange of $3.1 million, revenue increased $5.9 million, or 4.9%, attributable to growth across all markets. The growth was driven by higher revenue of approximately $2 million from WWN alliances from higher global customer product usage and cross-border data sales, approximately $2 million from Europe and approximately $1 million from the U.K. primarily attributable to growth in Third Party Risk and Compliance solutions and approximately $1 million from our Asia markets driven by growth in API solutions and local market solutions.
Sales & Marketing
For the three months ended March 31, 2025, International Sales & Marketing revenue increased $1.1 million, or 1.9% (4.2% before the effect of foreign exchange) compared to the three months ended March 31, 2024. Excluding the negative impact of foreign exchange of $1.3 million, organic revenue increased $2.4 million, or 4.2%, primarily due to higher revenue from WWN alliances driven by higher product royalties.
Operating Costs
Consolidated operating costs were as follows (In millions):
| Three months ended March 31, | |||||||||||||||||||||||
| 2025 | 2024 | $ Increase (decrease) | % Increase (decrease) | ||||||||||||||||||||
Cost of services (exclusive of depreciation and amortization) | $ | 227.8 | $ | 224.1 | $ | 3.7 | 1.7 | % | |||||||||||||||
Selling and administrative expenses | 169.1 | 176.4 | (7.3) | (4.2) | % | ||||||||||||||||||
| Depreciation and amortization | 144.7 | 144.0 | 0.7 | 0.5 | % | ||||||||||||||||||
| Restructuring charges | 2.9 | 3.4 | (0.5) | (15.9) | % | ||||||||||||||||||
| Operating costs | $ | 544.5 | $ | 547.9 | $ | (3.4) | (0.6) | % | |||||||||||||||
| Operating income (loss) | $ | 35.3 | $ | 16.6 | $ | 18.7 | 112.9 | % | |||||||||||||||
Cost of Services (exclusive of depreciation and amortization)
Cost of services (exclusive of depreciation and amortization) was $227.8 million for the three months ended March 31, 2025, an increase of $3.7 million, or 1.7%, compared to the three months ended March 31, 2024, primarily due to higher data acquisition costs of approximately $10 million and higher net personnel costs of approximately $2 million, partially offset by lower cloud infrastructure costs of approximately $7 million incurred to modernize our technology infrastructure as we are reaching completion of the migration to the new technology systems. Total cost of services was favorably impacted by foreign exchange of $0.6 million for the three months ended March 31, 2025, compared to the prior year quarter.
Selling and Administrative Expenses
Selling and administrative expenses were $169.1 million for the three months ended March 31, 2025, a decrease of $7.3 million, or 4.2%, compared to the three months ended March 31, 2024, driven by lower net personnel costs of approximately $8 million. Total selling and administrative expenses were favorably impacted by foreign exchange of $1.4 million for the three months ended March 31, 2025, compared to the prior year quarter.
Depreciation and Amortization
Depreciation and amortization expenses were $144.7 million for the three months ended March 31, 2025, an increase of $0.7 million, or 0.5%, compared to the three months ended March 31, 2024, primarily due to higher amortization resulting from increased internally developed software subject to amortization, partially offset by lower amortization related to intangible assets recognized in connection with historical merger and acquisition transactions.
38
Restructuring Charges
Restructuring charges were $2.9 million for the three months ended March 31, 2025, a decrease of $0.5 million, or 15.9%, compared to the three months ended March 31, 2024, primarily due to lower severance and lease costs in the current year quarter in North America.
Operating Income (Loss)
Consolidated operating income was $35.3 million for the three months ended March 31, 2025, an increase of $18.7 million, or 112.9%, compared to the three months ended March 31, 2024. The increase in operating income was primarily driven by higher revenue of $15.3 million, and lower costs of approximately $7 million related to cloud infrastructure costs and approximately $6 million related to net personnel costs, partially offset by higher data acquisition costs of approximately $10 million.
Adjusted EBITDA and Adjusted EBITDA Margin
Adjusted EBITDA and adjusted EBITDA margin by segment was as follows (In millions):
| Three months ended March 31, | |||||||||||||||||||||||
| 2025 | 2024 | $ Increase (decrease) | % Increase (decrease) | ||||||||||||||||||||
| North America: | |||||||||||||||||||||||
| Adjusted EBITDA | $ | 166.2 | $ | 152.1 | $ | 14.1 | 9.3 | % | |||||||||||||||
| Adjusted EBITDA margin | 41.8 | % | 39.3 | % | N/A | 250 | bps | ||||||||||||||||
| International: | |||||||||||||||||||||||
| Adjusted EBITDA | $ | 60.5 | $ | 64.3 | $ | (3.8) | (5.8) | % | |||||||||||||||
| Adjusted EBITDA margin | 33.3 | % | 36.1 | % | N/A | (280) | bps | ||||||||||||||||
| Corporate and other: | |||||||||||||||||||||||
| Adjusted EBITDA | $ | (15.8) | $ | (15.1) | $ | (0.7) | (5.0) | % | |||||||||||||||
| Consolidated total: | |||||||||||||||||||||||
| Adjusted EBITDA | $ | 210.9 | $ | 201.3 | $ | 9.6 | 4.8 | % | |||||||||||||||
| Adjusted EBITDA margin | 36.4 | % | 35.7 | % | N/A | 70 | bps | ||||||||||||||||
Consolidated
Consolidated net loss margin on a GAAP basis was 2.7% for the three months ended March 31, 2025, compared to a net loss margin of 4.1% for the three months ended March 31, 2024, an improvement of 140 basis points. Consolidated adjusted EBITDA was $210.9 million for the three months ended March 31, 2025, compared to $201.3 million for the three months ended March 31, 2024, an increase of $9.6 million, or 4.8%, primarily due to revenue growth and lower cloud infrastructure costs, partially offset by higher data acquisition costs. Consolidated adjusted EBITDA growth over the prior year quarter was negatively impacted by foreign exchange of approximately $3 million. Consolidated adjusted EBITDA margin was 36.4% for the three months ended March 31, 2025, compared to 35.7% for the prior year quarter, an increase of 70 basis points.
North America Segment
North America adjusted EBITDA was $166.2 million for the three months ended March 31, 2025, an increase of $14.1 million, or 9.3% compared to the three months ended March 31, 2024. The increase in adjusted EBITDA was primarily due to revenue growth and lower costs driven by net personnel costs, selling and marketing expenses and cloud infrastructure costs, partially offset by higher data acquisition costs. Adjusted EBITDA margin was 41.8% for the three months ended March 31, 2025, compared to 39.3% for the prior year quarter, an increase of 250 basis points.
International Segment
International adjusted EBITDA was $60.5 million for the three months ended March 31, 2025, a decrease of $3.8 million, or 5.8%, compared to the three months ended March 31, 2024. The decrease in adjusted EBITDA was primarily due to
39
higher costs driven by data acquisition costs, net personnel costs and selling expenses, partially offset by revenue growth from the underlying business. Adjusted EBITDA compared to the prior year quarter was negatively impacted by foreign exchange of approximately $3 million. Adjusted EBITDA margin was 33.3% for the three months ended March 31, 2025, compared to 36.1% for the prior year quarter, a decrease of 280 basis points.
Corporate and Other
Corporate adjusted EBITDA was a loss of $15.8 million for the three months ended March 31, 2025, a change of $0.7 million, or 5.0%, compared to the three months ended March 31, 2024. The change in adjusted EBITDA was primarily attributable to higher net personnel costs.
Interest Income (Expense) — Net
Interest income (expense) – net was as follows (In millions):
| Three months ended March 31, | |||||||||||||||||||||||
| 2025 | 2024 | $ Change | % Change | ||||||||||||||||||||
| Interest income | $ | 1.5 | $ | 1.6 | $ | (0.1) | (6.1) | % | |||||||||||||||
| Interest expense | (52.9) | (85.3) | 32.4 | 38.0 | % | ||||||||||||||||||
| Interest income (expense) – net | $ | (51.4) | $ | (83.7) | $ | 32.3 | 38.6 | % | |||||||||||||||
Interest expense decreased $32.4 million for the three months ended March 31, 2025 compared to the three months ended March 31, 2024, primarily due to the write off of debt issuance costs and discount of $37.1 million in the prior year period in connection with the term loan amendment and reduced interest expense of $7.9 million in the current year quarter primarily as a result of lower interest rates, partially offset by higher amortization loss of $12.4 million in the current year quarter related to the interest rate swap amendment.
Other income (expense) - net was as follows (In millions):
| Three months ended March 31, | |||||||||||||||||||||||
| 2025 | 2024 | $ Change | % Change | ||||||||||||||||||||
| Non-operating pension-related income | $ | 5.7 | $ | 4.9 | $ | 0.8 | 16.3 | % | |||||||||||||||
| Miscellaneous other income (expense) – net | (4.4) | (4.8) | 0.4 | 8.3 | % | ||||||||||||||||||
| Other income (expense) – net | $ | 1.3 | $ | 0.1 | $ | 1.2 | 851.5 | % | |||||||||||||||
Non-operating pension-related income increased $0.8 million for the three months ended March 31, 2025, compared to the three months ended March 31, 2024, primarily due to higher expected return on plan assets in the current year period.
The improvement in miscellaneous other income (expense) - net of $0.4 million for the three months ended March 31, 2025, was primarily due to lower fees related to the accounts receivable securitization facility.
Provision for Income Taxes
The effective tax rate for the three months ended March 31, 2025 was (2.7)%, reflecting a tax expense of $0.4 million on pre-tax loss of $14.8 million, compared to 66.0% for the three months ended March 31, 2024, which reflected a tax benefit of $44.2 million on pre-tax loss of $67.0 million. The change in the effective tax rate for the three months ended March 31, 2025 compared to the prior year quarter was primarily the result of an uncertain tax position benefit resulting from an audit settlement in the prior year quarter.
Net Income (Loss)
Net income (loss) attributable to Dun & Bradstreet Holdings, Inc. was a net loss of $15.8 million, or a loss per share of $0.04, for the three months ended March 31, 2025, compared to a net loss of $23.2 million, or a loss per share of $0.05, for the
40
three months ended March 31, 2024. The improvement of $7.4 million for the three months ended March 31, 2025 compared to the prior year quarter was primarily due to lower net interest expense of $32.3 million primarily due to the write off of debt issuance costs and discount of $37.1 million in the prior year in connection with the term loan amendment and higher operating income of $18.7 million in the current year quarter (as discussed above in Operating Income (Loss)), partially offset by a higher tax expense of $44.6 million in the current year quarter.
Adjusted Net Income and Adjusted Net Earnings per Diluted Share
Adjusted net income was $90.9 million, or adjusted net earnings per diluted share of $0.21, for the three months ended March 31, 2025, compared to adjusted net income of $85.0 million, or adjusted net earnings per diluted share of $0.20, for the three months ended March 31, 2024. The increase in adjusted net income was primarily attributable to higher adjusted EBITDA (as discussed above in Adjusted EBITDA) and lower interest expense in the current year quarter, partially offset by higher depreciation and amortization and tax expense.
Liquidity and Capital Resources
Overview
Our primary sources of liquidity consist of cash flows provided by operating activities, cash and cash equivalents on hand and our short-term borrowings under our senior secured credit facility. Our principal uses of liquidity are working capital, capital investments (including computer software), debt service, business acquisitions and other general corporate purposes.
We believe that cash provided by operating activities, supplemented as needed with available financing arrangements, is sufficient to meet our short-term needs for at least the next twelve months, including interest payments, contractual obligations, capital expenditures, dividend payments, stock repurchases, tax liabilities and restructuring charges. We continue to generate substantial cash from ongoing operating activities and manage our capital structure to meet short- and long-term objectives including investing in existing businesses and strategic acquisitions. In addition, we have the ability to use the short-term borrowings from the Revolving Facility to supplement the seasonality in the timing of receipts in order to fund our working capital needs.
Our future capital requirements will depend on many factors that are difficult to predict, including the size, timing and structure of any future acquisitions, future capital investments and future results of operations. Our access to the capital markets can be impacted by factors outside of our control, including fluctuation in interest rates, inflation, potential economic slowdowns or recession and the ongoing global trade tensions and geopolitical conflicts. Currently, while we do not expect our ability to fund our operating needs to be affected by the current market volatility and uncertainties for the foreseeable future, the ultimate impact will be difficult to predict, and depends on, among many factors, the duration of inflation, the severity of the economic slowdown, the current global geopolitical risks, such as the Middle East and Russia/Ukraine conflicts, and global trade tensions and their effects on global market conditions and on our clients and vendors, which continue to be uncertain at this time and cannot be predicted. We actively manage the impact of rising interest rates by reducing debt and entering into interest rate swaps and cross-currency swaps.
Cash Flow Overview
As of March 31, 2025, we had cash and cash equivalents of $241.3 million, of which $207.4 million was held by our foreign operations. We utilize a variety of planning strategies in an effort to ensure that our worldwide cash is available when and where it is needed. Subsequent to the enactment of the Tax Cuts and Jobs Act ("2017 Act"), a significant portion of the cash and cash equivalents held by our foreign subsidiaries is no longer subject to U.S. income tax upon repatriation to the United States. However, a portion of our cash held by our foreign operations is still subject to foreign income tax or withholding tax upon repatriation. As a result, we intend to reinvest indefinitely all earnings post 2017 from our China and India subsidiaries. Cash held in our China and India operations totaled $74.9 million as of March 31, 2025.
Information about our cash flows, by category, is presented in the Consolidated Statements of Cash Flows. The following table summarizes our cash flows for the periods presented (In millions):
41
| Three months ended March 31, | |||||||||||||||||
| 2025 | 2024 | $ Increase (decrease) | |||||||||||||||
| Net cash provided by (used in) operating activities | $ | 136.9 | $ | 158.9 | $ | (22.0) | |||||||||||
| Net cash provided by (used in) investing activities | (55.1) | (54.9) | (0.2) | ||||||||||||||
| Net cash provided by (used in) financing activities | (44.6) | (75.7) | 31.1 | ||||||||||||||
| Total cash provided during the period before the effect of exchange rate changes | $ | 37.2 | $ | 28.3 | $ | 8.9 | |||||||||||
Cash Provided by (Used in) Operating Activities
Lower operating cash flows of $22.0 million in the three months ended March 31, 2025, compared to the three months ended March 31, 2024, was primarily driven by higher payments for income taxes in the current year period, partially offset by lower interest payments.
We expect operating cash requirements in 2025 to be primarily related to payments for interest, contractual obligations, tax liability and other working capital needs. A portion of our outstanding debt is subject to the variability of interest rates. A 100 basis point increase or decrease in the weighted average interest rate would result in an incremental increase or decrease in annual interest expense of approximately $31 million, respectively. We mitigate the exposure from the variation of interest rates by entering into interest rate swap arrangements, and as a result we reduce the net exposure to approximately $10 million. See Note 9 to the unaudited condensed consolidated financial statements for further discussion. In addition, we typically have various contractual obligations in our normal course of business, including those recorded as liabilities in our consolidated balance sheet, and certain purchase commitments that are not recognized, but are disclosed in the notes to our consolidated financial statements. A significant portion of these contractual obligations are related to payments for enterprise-wide information-technology services. We expect to continue to generate substantial cash from ongoing operating activities.
Cash Provided by (Used in) Investing Activities
Higher net cash used in investing activities of $0.2 million for the three months ended March 31, 2025, compared to the three months ended March 31, 2024, was primarily due to higher net cash payments of $11.3 million for settlement of foreign exchange contracts and higher capital expenditures of $0.5 million in the current year period, partially offset by lower additions to computer software of $11.5 million in the current year period.
Cash Provided by (Used in) Financing Activities
The decrease in net cash used in financing activities of $31.1 million during the three months ended March 31, 2025, compared to the three months ended March 31, 2024, was primarily due to lower term loan repayments of $3,095.8 million in the current year period and higher net proceeds of $30.0 million from borrowings on the Revolving Facility in the current year period, partially offset by higher net debt issuance proceeds of $3,077.0 million in the prior year period.
Capital Resources and Debt
In addition to cash generated from our operating activities, we also borrow from time to time from our credit facility and issue long-term debt.
Below is a summary of our borrowings as of March 31, 2025 and December 31, 2024 (In millions):
42
| March 31, 2025 | December 31, 2024 | ||||||||||||||||||||||||||||||||||||||||
| Maturity | Principal amount | Debt issuance costs and discount | Carrying value | Principal amount | Debt issuance costs and discount | Carrying value | |||||||||||||||||||||||||||||||||||
| Debt maturing within one year: | |||||||||||||||||||||||||||||||||||||||||
2029 Term loan B | January 18, 2029 | $ | 31.0 | $ | — | $ | 31.0 | $ | 31.0 | $ | — | $ | 31.0 | ||||||||||||||||||||||||||||
| Total short-term debt | $ | 31.0 | $ | — | $ | 31.0 | $ | 31.0 | $ | — | $ | 31.0 | |||||||||||||||||||||||||||||
| Debt maturing after one year: | |||||||||||||||||||||||||||||||||||||||||
2029 Term loan B | January 18, 2029 | $ | 3,041.6 | $ | 16.3 | $ | 3,025.3 | $ | 3,049.4 | $ | 17.4 | $ | 3,032.0 | ||||||||||||||||||||||||||||
| Revolving facility | February 15, 2029 | 15.0 | — | 15.0 | 10.0 | — | 10.0 | ||||||||||||||||||||||||||||||||||
| 5.000% Senior unsecured notes | December 15, 2029 | 460.0 | 4.1 | 455.9 | 460.0 | 4.3 | 455.7 | ||||||||||||||||||||||||||||||||||
| Total long-term debt | $ | 3,516.6 | $ | 20.4 | $ | 3,496.2 | $ | 3,519.4 | $ | 21.7 | $ | 3,497.7 | |||||||||||||||||||||||||||||
| Total debt | $ | 3,547.6 | $ | 20.4 | $ | 3,527.2 | $ | 3,550.4 | $ | 21.7 | $ | 3,528.7 | |||||||||||||||||||||||||||||
See Note 12 to the unaudited condensed consolidated financial statements for detailed discussion related to our debt as of March 31, 2025 and December 31, 2024.
Contractual Obligations
See Notes 13, 12, 7 and 20 to the consolidated financial statements for the year ended December 31, 2024 included in the 2024 Annual Report on Form 10-K, which we filed on February 21, 2025, for expected payments for our debt, leases, pension obligations and vendor commitments, respectively. Further, see Note 11 to the unaudited condensed consolidated financial statements for the three months ended March 31, 2025 for a detailed discussion of data contracts entered into during the first quarter of 2025.
Off-Balance Sheet Arrangements
We do not have any transactions, obligations or relationships that could be considered off-balance sheet arrangements, other than our foreign exchange forward contracts, interest rate swaps and cross-currency swaps discussed in Note 9 to the unaudited condensed consolidated financial statements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Our market risks primarily consist of the impact of changes in currency exchange rates on assets and liabilities, the impact of changes in the market value of certain of our investments and the impact of changes in interest rates on our borrowing costs and fair value calculations. As of March 31, 2025, no material change had occurred in our market risks, compared with the disclosure in our Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 21, 2025.
Item 4. Controls and Procedures
As of March 31, 2025, under the supervision and with the participation of our Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), management has evaluated the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as of the end of the period covered by this report.
Our disclosure controls and procedures are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.
43
There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their control objectives.
Based upon their evaluation, our CEO and CFO have concluded that as of March 31, 2025, our disclosure controls and procedures were effective to provide reasonable assurance that the information required to be disclosed by us in the reports we file or submit with the SEC are recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and is accumulated and communicated to our management, including the principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rules 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the quarter ended March 31, 2025 covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Part II: OTHER INFORMATION
Item 1. Legal Proceedings
Information in response to this Item is included in “Part I — Item 1. — Note 17 — Contingencies” and is incorporated by reference into Part II of this Quarterly Report on Form 10-Q.
Item 1A. Risk Factors
There have been no material changes in our risk factors since our Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 21, 2025.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
The following table provides the share repurchase activity during the three months ended March 31, 2025:
Periods | Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased as part of Publicly Announced Program | Maximum Number of Currently Authorized Shares that May Yet Be Purchased Under the Program | Approximate Dollar Value of Currently Authorized Shares that May Yet Be Purchased Under the Program (1) | |||||||||||||||||||||||||||
(Dollar amounts in millions, except share data) | ||||||||||||||||||||||||||||||||
January 1 - 31, 2025 | — | $ | — | — | ||||||||||||||||||||||||||||
February 1 - 28, 2025 | — | $ | — | — | ||||||||||||||||||||||||||||
March 1 - 31, 2025 | — | $ | — | — | ||||||||||||||||||||||||||||
Total | — | — | 9,038,640 | $ | 80.8 | |||||||||||||||||||||||||||
(1)Based on the closing stock price of $8.94 on March 31, 2025.
On April 30, 2024, our Board of Directors authorized a three-year stock repurchase program, (the "2024 Stock Repurchase Program"), under which the Company may repurchase up to 10.0 million shares of its common stock. Purchases may be made from time to time in the open market at prevailing prices or in privately negotiated transactions through April 30, 2027. The repurchase program does not obligate the Company to acquire any specific number of shares and may be suspended or terminated at any time. There was no share repurchase activity during the three months ended March 31, 2025. Subsequent to entering into the definitive agreement with Clearlake on March 23, 2025, the Company will not repurchase any shares under the 2024 Stock Repurchase Program.
Item 3. Defaults upon Senior Securities
None
Item 4. Mine Safety Disclosures
44
Not Applicable
Item 5. Other Information
In the first quarter of 2025, no director or officer (as defined in Exchange Act Rule 16a-1(f)) of the Company adopted terminated
Item 6. Exhibits
| Exhibit Number | Description | |||||||
| 2.1† | ||||||||
| 10.1 | ||||||||
| 10.2 | ||||||||
| 31.1 | ||||||||
| 31.2 | ||||||||
| 32.1 | ||||||||
| 32.2 | ||||||||
| 101 | The following materials from Dun & Bradstreet Holdings, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) the Condensed Consolidated Statement of Operations and Comprehensive Income (Loss) (Unaudited), (ii) the Condensed Consolidated Balance Sheets (Unaudited), (iii) the Condensed Consolidated Statements of Cash Flows (Unaudited), (iv) the Condensed Consolidated Statements of Stockholders' Equity (Unaudited), and (v) the Notes to the Condensed Consolidated Financial Statements. | |||||||
| 104 | Cover Page Interactive Data File (embedded within the iXBRL document and contained in Exhibit 101). | |||||||
| † Schedules have been omitted pursuant to Item 601(a)(5) and Item 601(b)(2) of Regulation S-K. The Company hereby undertakes to furnish supplemental copies of any of the omitted schedules upon request by the SEC; provided, however, that the Company may request confidential treatment pursuant to Rule 24b-2 of the Exchange Act, for any schedules so furnished. | ||||||||
* Incorporated by reference.
† Management compensatory plan or arrangement.
45
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| DUN & BRADSTREET HOLDINGS, INC. | |||||||||||
| By: | /s/ BRYAN T. HIPSHER | ||||||||||
| Bryan T. Hipsher | |||||||||||
| Date: | May 1, 2025 | Chief Financial Officer | |||||||||
| (Principal Financial Officer) | |||||||||||
| By: | /s/ ANTHONY PIETRONTONE | ||||||||||
| Anthony Pietrontone | |||||||||||
| Date: | May 1, 2025 | Chief Accounting Officer | |||||||||
| (Principal Accounting Officer) | |||||||||||
46